| Year |
Citation |
Score |
| 2023 |
Orhan F, Goiny M, Becklén M, Mathé L, Piehl F, Schwieler L, Fatouros-Bergman H, Farde L, Cervenka S, Sellgren CM, Engberg G, Erhardt S. CSF dopamine is elevated in first-episode psychosis and associates to symptom severity and cognitive performance. Schizophrenia Research. 257: 34-40. PMID 37271040 DOI: 10.1016/j.schres.2023.05.012 |
0.565 |
|
| 2023 |
Jangard S, Jayaram-Lindström N, Isacsson NH, Matheson GJ, Plavén-Sigray P, Franck J, Borg J, Farde L, Cervenka S. Striatal dopamine D2 receptor availability as a predictor of subsequent alcohol use in social drinkers. Addiction (Abingdon, England). PMID 36710462 DOI: 10.1111/add.16144 |
0.588 |
|
| 2022 |
Dahl K, Johnström P, Forsberg-Morén A, Gustafsson B, Miranda-Azpiazu P, Khani Y, Halldin C, Farde L, Elmore CS, Schou M. Synthesis and Preclinical Evaluation of [C]AZ11895530 for PET Imaging of the Serotonin 1A Receptor. Acs Chemical Neuroscience. PMID 35802379 DOI: 10.1021/acschemneuro.2c00205 |
0.403 |
|
| 2021 |
Plavén-Sigray P, Ikonen Victorsson P, Santillo A, Matheson GJ, Lee M, Collste K, Fatouros-Bergman H, Sellgren CM, Erhardt S, Agartz I, Halldin C, Farde L, Cervenka S. Thalamic dopamine D2-receptor availability in schizophrenia: a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysis. Molecular Psychiatry. PMID 34759359 DOI: 10.1038/s41380-021-01349-x |
0.612 |
|
| 2021 |
Lee M, Fatouros-Bergman H, Plavén-Sigray P, Ikonen Victorsson P, Sellgren CM, Erhardt S, Flyckt L, Farde L, Cervenka S. No association between cortical dopamine D2 receptor availability and cognition in antipsychotic-naive first-episode psychosis. Npj Schizophrenia. 7: 46. PMID 34548499 DOI: 10.1038/s41537-021-00176-x |
0.609 |
|
| 2020 |
Freiburghaus T, Svensson JE, Matheson GJ, Plavén-Sigray P, Lundberg J, Farde L, Cervenka S. Low convergent validity of [C]raclopride binding in extrastriatal brain regions: a PET study of within-subject correlations with [C]FLB 457. Neuroimage. 117523. PMID 33144221 DOI: 10.1016/j.neuroimage.2020.117523 |
0.65 |
|
| 2020 |
Varnäs K, Finnema SJ, Johnström P, Arakawa R, Halldin C, Eriksson LI, Farde L. Effects of sevoflurane anaesthesia on radioligand binding to monoamine oxidase-B in vivo. British Journal of Anaesthesia. PMID 33036760 DOI: 10.1016/j.bja.2020.08.052 |
0.342 |
|
| 2020 |
Andersson M, Tangen Ä, Farde L, Bölte S, Halldin C, Borg J, Lundberg J. Serotonin transporter availability in adults with autism-a positron emission tomography study. Molecular Psychiatry. PMID 32848204 DOI: 10.1038/S41380-020-00868-3 |
0.31 |
|
| 2020 |
Tjerkaski J, Cervenka S, Farde L, Matheson GJ. Kinfitr - an open-source tool for reproducible PET modelling: validation and evaluation of test-retest reliability. Ejnmmi Research. 10: 77. PMID 32642865 DOI: 10.1186/s13550-020-00664-8 |
0.57 |
|
| 2020 |
Matheson GJ, Plavén-Sigray P, Louzolo A, Borg J, Farde L, Petrovic P, Cervenka S. Dopamine D1 receptor availability is not associated with delusional ideation measures of psychosis proneness. Schizophrenia Research. PMID 32616361 DOI: 10.1016/J.Schres.2020.06.001 |
0.671 |
|
| 2020 |
Cselényi Z, Jucaite A, Kristensson C, Stenkrona P, Ewing P, Varrone A, Johnström P, Schou M, Vazquez-Romero A, Moein MM, Bolin M, Siikanen J, Grybäck P, Larsson B, Halldin C, ... ... Farde L, et al. Quantification and reliability of [C]VC - 002 binding to muscarinic acetylcholine receptors in the human lung - a test-retest PET study in control subjects. Ejnmmi Research. 10: 59. PMID 32495011 DOI: 10.1186/S13550-020-00634-0 |
0.421 |
|
| 2020 |
Nag S, Varnas K, Arakawa R, Jahan M, Schou M, Farde L, Halldin C. Synthesis, biodistribution and radiation dosimetry of a novel mGluR5 radioligand: [18F]AZD9272. Acs Chemical Neuroscience. PMID 32167745 DOI: 10.1021/Acschemneuro.9B00680 |
0.341 |
|
| 2020 |
Tiger M, Svensson J, Liberg B, Saijo T, Schain M, Halldin C, Farde L, Lundberg J. A [ C]raclopride positron emission tomography study of dopamine-D receptor binding in patients with severe major depressive episodes before and after electroconvulsive therapy and compared to control subjects. Psychiatry and Clinical Neurosciences. PMID 31943514 DOI: 10.1111/Pcn.12980 |
0.315 |
|
| 2020 |
Victorsson P, Plavén-Sigray P, Matheson G, Santillo A, Lee M, Collste K, Fatouros-Bergman H, Agartz I, Halldin C, Farde L, Cervenka S. M7. LOWER THALAMIC DOPAMINE D2-RECEPTOR BINDING IN DRUG-NAIVE PATIENTS WITH PSYCHOSIS – A REPLICATION STUDY USING POSITRON EMISSION TOMOGRAPHY Schizophrenia Bulletin. 46: S135-S136. DOI: 10.1093/Schbul/Sbaa030.319 |
0.69 |
|
| 2019 |
Svensson JE, Schain M, Plavén-Sigray P, Cervenka S, Tiger M, Nord M, Halldin C, Farde L, Lundberg J. In response to the letter "[C]raclopride and extrastriatal binding to D2/3 receptors". Neuroimage. 116371. PMID 31756518 DOI: 10.1016/J.Neuroimage.2019.116371 |
0.636 |
|
| 2019 |
Lindberg A, Arakawa R, Nogami T, Nag S, Schou M, Elmore CS, Farde L, Pike VW, Halldin C. Potential for imaging the high-affinity state of the 5-HT receptor: a comparison of three PET radioligands with differing intrinsic activity. Ejnmmi Research. 9: 100. PMID 31754940 DOI: 10.1186/S13550-019-0570-1 |
0.399 |
|
| 2019 |
Varnäs K, Cselényi Z, Arakawa R, Nag S, Stepanov V, Moein MM, Johnström P, Kingston L, Elmore CS, Halldin C, Farde L. The pro-psychotic metabotropic glutamate receptor compounds fenobam and AZD9272 share binding sites with monoamine oxidase-B inhibitors in humans. Neuropharmacology. 107809. PMID 31589885 DOI: 10.1016/J.Neuropharm.2019.107809 |
0.467 |
|
| 2019 |
Svensson JE, Schain M, Plavén-Sigray P, Cervenka S, Tiger M, Nord M, Halldin C, Farde L, Lundberg J. Validity and reliability of extrastriatal [C]raclopride binding quantification in the living human brain. Neuroimage. 116143. PMID 31473354 DOI: 10.1016/J.Neuroimage.2019.116143 |
0.684 |
|
| 2019 |
Tuisku J, Plavén-Sigray P, Gaiser EC, Airas L, Al-Abdulrasul H, Brück A, Carson RE, Chen MK, Cosgrove KP, Ekblad L, Esterlis I, Farde L, Forsberg A, Halldin C, Helin S, et al. Effects of age, BMI and sex on the glial cell marker TSPO - a multicentre [C]PBR28 HRRT PET study. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31363804 DOI: 10.1007/S00259-019-04403-7 |
0.621 |
|
| 2019 |
Forsberg A, Lampa J, Estelius J, Cervenka S, Farde L, Halldin C, Lekander M, Olgart Höglund C, Kosek E. Disease activity in rheumatoid arthritis is inversely related to cerebral TSPO binding assessed by [C]PBR28 positron emission tomography. Journal of Neuroimmunology. 334: 577000. PMID 31260948 DOI: 10.1016/J.Jneuroim.2019.577000 |
0.593 |
|
| 2019 |
Yang KC, Stepanov V, Amini N, Martinsson S, Takano A, Bundgaard C, Bang-Andersen B, Sanchez C, Halldin C, Farde L, Finnema SJ. Effect of clinically relevant doses of vortioxetine and citalopram on serotonergic PET markers in the nonhuman primate brain. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31216565 DOI: 10.1038/S41386-019-0442-4 |
0.44 |
|
| 2019 |
Varrone A, Varnäs K, Jucaite A, Cselényi Z, Johnström P, Schou M, Vazquez-Romero A, Moein MM, Halldin C, Brown AP, Vishwanathan K, Farde L. A PET study in healthy subjects of brain exposure of C-labelled osimertinib - A drug intended for treatment of brain metastases in non-small cell lung cancer. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X19843776. PMID 31006308 DOI: 10.1177/0271678X19843776 |
0.429 |
|
| 2019 |
Stenkrona P, Matheson GJ, Halldin C, Cervenka S, Farde L. D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients. The International Journal of Neuropsychopharmacology. PMID 30958880 DOI: 10.1093/Ijnp/Pyz017 |
0.691 |
|
| 2019 |
Schou M, Ewing P, Cselenyi Z, Fridén M, Takano A, Halldin C, Farde L. Pulmonary PET imaging confirms preferential lung target occupancy of an inhaled bronchodilator. Ejnmmi Research. 9: 9. PMID 30694407 DOI: 10.1186/S13550-019-0479-8 |
0.397 |
|
| 2018 |
Jahan M, Johnström P, Selvaraju RK, Svedberg M, Winzell MS, Bernström J, Kingston L, Schou M, Jia Z, Skrtic S, Johansson L, Korsgren O, Farde L, Halldin C, Eriksson O. The development of a GPR44 targeting radioligand [C]AZ12204657 for in vivo assessment of beta cell mass. Ejnmmi Research. 8: 113. PMID 30588560 DOI: 10.1186/S13550-018-0465-6 |
0.305 |
|
| 2018 |
Plavén-Sigray P, Matheson GJ, Cselényi Z, Jucaite A, Farde L, Cervenka S. Test-retest reliability and convergent validity of (R)-[C]PK11195 outcome measures without arterial input function. Ejnmmi Research. 8: 102. PMID 30498919 DOI: 10.1186/s13550-018-0455-8 |
0.613 |
|
| 2018 |
Griffioen G, Matheson GJ, Cervenka S, Farde L, Borg J. Serotonin 5-HT receptor binding and self-transcendence in healthy control subjects-a replication study using Bayesian hypothesis testing. Peerj. 6: e5790. PMID 30479884 DOI: 10.7717/peerj.5790 |
0.628 |
|
| 2018 |
Varnäs K, Cselényi Z, Jucaite A, Halldin C, Svenningsson P, Farde L, Varrone A. PET imaging of [C]PBR28 in Parkinson's disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30270409 DOI: 10.1007/S00259-018-4161-6 |
0.396 |
|
| 2018 |
Orhan F, Schwieler L, Fatouros-Bergman H, Malmqvist A, Cervenka S, Collste K, Flyckt L, Farde L, Sellgren CM, Piehl F, Engberg G, Erhardt S. Increased number of monocytes and plasma levels of MCP-1 and YKL-40 in first-episode psychosis. Acta Psychiatrica Scandinavica. 138: 432-440. PMID 30132802 DOI: 10.1111/acps.12944 |
0.49 |
|
| 2018 |
Stenkrona P, Matheson GJ, Cervenka S, Sigray PP, Halldin C, Farde L. [C]SCH23390 binding to the D-dopamine receptor in the human brain-a comparison of manual and automated methods for image analysis. Ejnmmi Research. 8: 74. PMID 30069645 DOI: 10.1186/S13550-018-0416-2 |
0.722 |
|
| 2018 |
Yang KC, Takano A, Halldin C, Farde L, Finnema SJ. Serotonin concentration enhancers at clinically relevant doses reduce [C]AZ10419369 binding to the 5-HT receptors in the nonhuman primate brain. Translational Psychiatry. 8: 132. PMID 30013068 DOI: 10.1038/S41398-018-0178-7 |
0.453 |
|
| 2018 |
Varnäs K, Juréus A, Finnema SJ, Johnström P, Raboisson P, Amini N, Takano A, Stepanov V, Halldin C, Farde L. The metabotropic glutamate receptor 5 radioligand [C]AZD9272 identifies unique binding sites in primate brain. Neuropharmacology. PMID 29608920 DOI: 10.1016/J.Neuropharm.2018.03.039 |
0.458 |
|
| 2018 |
Plavén-Sigray P, Matheson GJ, Gustavsson P, Stenkrona P, Halldin C, Farde L, Cervenka S. Is dopamine D1 receptor availability related to social behavior? A positron emission tomography replication study. Plos One. 13: e0193770. PMID 29543812 DOI: 10.1371/Journal.Pone.0193770 |
0.673 |
|
| 2018 |
Farde L, Plavén-Sigray P, Borg J, Cervenka S. Brain neuroreceptor density and personality traits: towards dimensional biomarkers for psychiatric disorders. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 373. PMID 29483342 DOI: 10.1098/rstb.2017.0156 |
0.586 |
|
| 2018 |
Fazio P, Svenningsson P, Cselényi Z, Halldin C, Farde L, Varrone A. Nigrostriatal dopamine transporter availability in early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29436751 DOI: 10.1002/Mds.27316 |
0.331 |
|
| 2018 |
Benlloch JM, González AJ, Pani R, Preziosi E, Jackson C, Murphy J, Barberá J, Correcher C, Aussenhofer S, Gareis D, Visvikis D, Bert J, Langstrom B, Farde L, Toth M, et al. The MINDVIEW project: First results. European Psychiatry : the Journal of the Association of European Psychiatrists. PMID 29398564 DOI: 10.1016/J.Eurpsy.2018.01.002 |
0.429 |
|
| 2018 |
Vishwanathan K, Varrone A, Varnas K, Jucaite A, Cselenyi Z, Johnstrom P, Schou M, Vasquez-Romero A, Moein MM, Halldin C, Brown AP, Farde L. Abstract CT013: Osimertinib displays high brain exposure in healthy subjects with intact blood-brain barrier: a microdose positron emission tomography (PET) study with 11C-labelled osimertinib Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Ct013 |
0.402 |
|
| 2017 |
Lindberg A, Nag S, Schou M, Takano A, Matsumoto J, Amini N, Elmore CS, Farde L, Pike VW, Halldin C. [(11)C]AZ10419096 - a full antagonist PET radioligand for imaging brain 5-HT1B receptors. Nuclear Medicine and Biology. 54: 34-40. PMID 28950161 DOI: 10.1016/J.Nucmedbio.2017.07.007 |
0.525 |
|
| 2017 |
Arakawa R, Farde L, Matsumoto J, Kanegawa N, Yakushev I, Yang KC, Takano A. Potential Effect of Prolonged Sevoflurane Anesthesia on the Kinetics of [(11)C]Raclopride in Non-human Primates. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 28916921 DOI: 10.1007/S11307-017-1120-8 |
0.433 |
|
| 2017 |
Yang KC, Stepanov V, Martinsson S, Ettrup A, Takano A, Knudsen GM, Halldin C, Farde L, Finnema SJ. Fenfluramine Reduces [11C]Cimbi-36 Binding to the 5-HT2A Receptor in the Nonhuman Primate Brain. The International Journal of Neuropsychopharmacology. 20: 683-691. PMID 28911007 DOI: 10.1093/Ijnp/Pyx051 |
0.518 |
|
| 2017 |
Matheson GJ, Plavén-Sigray P, Forsberg A, Varrone A, Farde L, Cervenka S. Assessment of simplified ratio-based approaches for quantification of PET [(11)C]PBR28 data. Ejnmmi Research. 7: 58. PMID 28733954 DOI: 10.1186/S13550-017-0304-1 |
0.644 |
|
| 2017 |
Matheson GJ, Stenkrona P, Cselényi Z, Plavén-Sigray P, Halldin C, Farde L, Cervenka S. Reliability of Volumetric and Surface-Based Normalisation and Smoothing Techniques for PET Analysis of the Cortex: A Test-Retest Analysis using [(11)C]SCH-23390. Neuroimage. PMID 28419852 DOI: 10.1016/J.Neuroimage.2017.04.031 |
0.624 |
|
| 2017 |
Forsberg A, Cervenka S, Jonsson Fagerlund M, Rasmussen LS, Zetterberg H, Erlandsson Harris H, Stridh P, Christensson E, Granström A, Schening A, Dymmel K, Knave N, Terrando N, Maze M, Borg J, ... ... Farde L, et al. The immune response of the human brain to abdominal surgery. Annals of Neurology. PMID 28253549 DOI: 10.1002/Ana.24909 |
0.591 |
|
| 2017 |
Collste K, Plavén-Sigray P, Fatouros-Bergman H, Victorsson P, Schain M, Forsberg A, Amini N, Aeinehband S, Erhardt S, Halldin C, Flyckt L, Farde L, Cervenka S. Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [(11)C]PBR28. Molecular Psychiatry. PMID 28194003 DOI: 10.1038/mp.2016.247 |
0.613 |
|
| 2017 |
Johnström P, Gutierrez PM, Varnäs K, Schou M, Takano A, Jones L, Mugundu G, McCoon P, Lyne P, Infante J, Falchook G, Patel M, Karlix J, Merchant M, Clarke J, ... ... Farde L, et al. Abstract 2641: AZD4635 A2Areceptor occupancy in cynomolgus monkey using PET and its application to an oncology clinical development program Cancer Research. 77: 2641-2641. DOI: 10.1158/1538-7445.Am2017-2641 |
0.409 |
|
| 2017 |
Collste K, Orhan F, Erhardt S, Schwieler L, Flyckt L, Farde L, Engberg G, Cervenka S. Associations between central chemokine levels and glial activation in first episode psychosis – a positron emission tomography study European Neuropsychopharmacology. 27. DOI: 10.1016/S0924-977X(17)31329-9 |
0.592 |
|
| 2016 |
Jucaite A, Cselényi Z, Lappalainen J, McCarthy DJ, Lee CM, Nyberg S, Varnäs K, Stenkrona P, Halldin C, Cross A, Farde L. GABAA receptor occupancy by subtype selective GABAAα2,3 modulators: PET studies in humans. Psychopharmacology. PMID 28013354 DOI: 10.1007/S00213-016-4506-4 |
0.367 |
|
| 2016 |
Yang KC, Stepanov V, Amini N, Martinsson S, Takano A, Nielsen J, Bundgaard C, Bang-Andersen B, Grimwood S, Halldin C, Farde L, Finnema SJ. Characterization of [(11)C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brain. European Journal of Nuclear Medicine and Molecular Imaging. PMID 27817159 DOI: 10.1007/S00259-016-3544-9 |
0.473 |
|
| 2016 |
Varnas K, Jureus A, Johnstrom P, Ahlgren C, Schott P, Schou M, Gruber S, Jerning E, Malmborg J, Halldin C, Afzelius L, Farde L. Integrated strategy for use of PET in non-human primate to confirm multi-target occupancy of novel psychotropic drugs: an example with AZD3676. The Journal of Pharmacology and Experimental Therapeutics. PMID 27402278 DOI: 10.1124/Jpet.116.234146 |
0.476 |
|
| 2016 |
Tiger M, Farde L, Rück C, Varrone A, Forsberg A, Lindefors N, Halldin C, Lundberg J. Low serotonin1B receptor binding potential in the anterior cingulate cortex in drug-free patients with recurrent major depressive disorder. Psychiatry Research. 253: 36-42. PMID 27269199 DOI: 10.1016/J.Pscychresns.2016.04.016 |
0.464 |
|
| 2016 |
Sonni I, Fazio P, Schain M, Halldin C, Svenningsson P, Farde L, Varrone A. Optimal acquisition time window and simplified quantification of dopamine transporter availability using 18F-FE-PE2I in healthy controls and Parkinson's disease patients. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27230923 DOI: 10.2967/Jnumed.115.171231 |
0.338 |
|
| 2016 |
Fazio P, Schain M, Varnäs K, Halldin C, Farde L, Varrone A. Mapping the distribution of serotonin transporter in the human brainstem with high resolution PET: Validation using post-mortem autoradiography data. Neuroimage. PMID 26994829 DOI: 10.1016/J.Neuroimage.2016.03.019 |
0.387 |
|
| 2016 |
Varnäs K, Finnema SJ, Stepanov V, Takano A, Tóth M, Svedberg M, Nielsen SM, Khanzhin NA, Juhl K, Bang-Andersen B, Halldin C, Farde L. Neurokinin-3 receptor binding in guinea pig, monkey and human brain: In vitro and in vivo imaging using the novel radioligand, [18F]Lu AF10628. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26993630 DOI: 10.1093/Ijnp/Pyw023 |
0.437 |
|
| 2016 |
Kanegawa N, Collste K, Forsberg A, Schain M, Arakawa R, Jucaite A, Lekander M, Höglund CO, Kosek E, Lampa J, Halldin C, Farde L, Varrone A, Cervenka S. In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects. Brain, Behavior, and Immunity. PMID 26820224 DOI: 10.1016/J.Bbi.2016.01.019 |
0.633 |
|
| 2016 |
Kanegawa N, Collste K, Forsberg A, Schain M, Arakawa R, Jucaite A, Lekander M, Höglund CO, Kosek E, Lampa J, Halldin C, Farde L, Varrone A, Cervenka S. Abstract # 1847 Cross-sectional and longitudinal associations between immune cells in blood and brain – A TSPO PET study in healthy control subjects Brain, Behavior, and Immunity. 57: e38. DOI: 10.1016/J.Bbi.2016.07.127 |
0.635 |
|
| 2015 |
Borg J, Cervenka S, Kuja-Halkola R, Matheson GJ, Jönsson EG, Lichtenstein P, Henningsson S, Ichimiya T, Larsson H, Stenkrona P, Halldin C, Farde L. Contribution of non-genetic factors to dopamine and serotonin receptor availability in the adult human brain. Molecular Psychiatry. PMID 26821979 DOI: 10.1038/Mp.2015.147 |
0.713 |
|
| 2015 |
Schou M, Varnas K, Jureus A, Ahlgren C, Malmquist J, Häggkvist J, Tari L, Wesolowski SS, Throner SR, Brown DG, Nilsson M, Johnström P, Finnema SJ, Nakao R, Amini N, ... ... Farde L, et al. Discovery and preclinical validation of [11C]AZ13153556, a novel probe for the histamine type-3 receptor. Acs Chemical Neuroscience. PMID 26529287 DOI: 10.1021/Acschemneuro.5B00268 |
0.454 |
|
| 2015 |
Collste K, Forsberg A, Varrone A, Amini N, Aeinehband S, Yakushev I, Halldin C, Farde L, Cervenka S. Test-retest reproducibility of [(11)C]PBR28 binding to TSPO in healthy control subjects. European Journal of Nuclear Medicine and Molecular Imaging. PMID 26293827 DOI: 10.1007/S00259-015-3149-8 |
0.652 |
|
| 2015 |
Rahman O, Takano A, Amini N, Dahl K, Kanegawa N, Långström B, Farde L, Halldin C. Synthesis of ([(11)C]carbonyl)raclopride and a comparison with ([(11)C]methyl)raclopride in a monkey PET study. Nuclear Medicine and Biology. 42: 893-8. PMID 26272268 DOI: 10.1016/J.Nucmedbio.2015.07.003 |
0.395 |
|
| 2015 |
Jucaite A, Svenningsson P, Rinne JO, Cselényi Z, Varnäs K, Johnström P, Amini N, Kirjavainen A, Helin S, Minkwitz M, Kugler AR, Posener JA, Budd S, Halldin C, Varrone A, ... Farde L, et al. Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease. Brain : a Journal of Neurology. 138: 2687-700. PMID 26137956 DOI: 10.1093/Brain/Awv184 |
0.368 |
|
| 2015 |
Mattsson P, Forsberg A, Persson J, Nyberg L, Nilsson LG, Halldin C, Farde L. β-Amyloid binding in elderly subjects with declining or stable episodic memory function measured with PET and [(11)C]AZD2184. European Journal of Nuclear Medicine and Molecular Imaging. PMID 26115835 DOI: 10.1007/S00259-015-3103-9 |
0.352 |
|
| 2015 |
Finnema SJ, Halldin C, Bang-Andersen B, Bundgaard C, Farde L. Serotonin transporter occupancy by escitalopram and citalopram in the non-human primate brain: a [(11)C]MADAM PET study. Psychopharmacology. 232: 4159-67. PMID 25980484 DOI: 10.1007/S00213-015-3961-7 |
0.522 |
|
| 2015 |
Finnema SJ, Scheinin M, Shahid M, Lehto J, Borroni E, Bang-Andersen B, Sallinen J, Wong E, Farde L, Halldin C, Grimwood S. Application of cross-species PET imaging to assess neurotransmitter release in brain. Psychopharmacology. PMID 25921033 DOI: 10.1007/S00213-015-3938-6 |
0.461 |
|
| 2015 |
Varrone A, Svenningsson P, Marklund P, Fatouros-Bergman H, Forsberg A, Halldin C, Nilsson LG, Farde L. 5-HT1B receptor imaging and cognition: a positron emission tomography study in control subjects and Parkinson's disease patients. Synapse (New York, N.Y.). 69: 365-74. PMID 25914348 DOI: 10.1002/Syn.21823 |
0.36 |
|
| 2015 |
Cselényi Z, Farde L. Quantification of blood flow-dependent component in estimates of beta-amyloid load obtained using quasi-steady-state standardized uptake value ratio. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 25873425 DOI: 10.1038/jcbfm.2015.66 |
0.341 |
|
| 2015 |
Schou M, Varnäs K, Lundquist S, Nakao R, Amini N, Takano A, Finnema SJ, Halldin C, Farde L. Large Variation in Brain Exposure of Reference CNS Drugs: a PET Study in Nonhuman Primates. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 25813017 DOI: 10.1093/Ijnp/Pyv036 |
0.34 |
|
| 2015 |
Fazio P, Svenningsson P, Forsberg A, Jönsson EG, Amini N, Nakao R, Nag S, Halldin C, Farde L, Varrone A. Quantitative Analysis of ¹⁸F-(E)-N-(3-Iodoprop-2-Enyl)-2β-Carbofluoroethoxy-3β-(4'-Methyl-Phenyl) Nortropane Binding to the Dopamine Transporter in Parkinson Disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 714-20. PMID 25791993 DOI: 10.2967/Jnumed.114.152421 |
0.335 |
|
| 2015 |
Hjorth S, Karlsson C, Jucaite A, Varnäs K, Wählby Hamrén U, Johnström P, Gulyás B, Donohue SR, Pike VW, Halldin C, Farde L. A PET study comparing receptor occupancy by five selective cannabinoid 1 receptor antagonists in non-human primates. Neuropharmacology. PMID 25791528 DOI: 10.1016/J.Neuropharm.2015.03.002 |
0.716 |
|
| 2015 |
Matheson GJ, Schain M, Almeida R, Lundberg J, Cselényi Z, Borg J, Varrone A, Farde L, Cervenka S. Diurnal and seasonal variation of the brain serotonin system in healthy male subjects. Neuroimage. 112: 225-31. PMID 25772667 DOI: 10.1016/J.Neuroimage.2015.03.007 |
0.646 |
|
| 2015 |
Johnström P, Bergman L, Varnäs K, Malmquist J, Halldin C, Farde L. Development of rapid multistep carbon-11 radiosynthesis of the myeloperoxidase inhibitor AZD3241 to assess brain exposure by PET microdosing. Nuclear Medicine and Biology. 42: 555-60. PMID 25726760 DOI: 10.1016/J.Nucmedbio.2015.02.001 |
0.393 |
|
| 2015 |
Finnema SJ, Hughes ZA, Haaparanta-Solin M, Stepanov V, Nakao R, Varnäs K, Varrone A, Arponen E, Marjamäki P, Pohjanoksa K, Vuorilehto L, Babalola PA, Solin O, Grimwood S, Sallinen J, ... Farde L, et al. Amphetamine decreases α2C-adrenoceptor binding of [11C]ORM-13070: a PET study in the primate brain. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 18. PMID 25522417 DOI: 10.1093/Ijnp/Pyu081 |
0.371 |
|
| 2015 |
Dahl K, Schou M, Ulin J, Sjöberg CO, Farde L, Halldin C. 11C-carbonylation reactions using gas-liquid segmented microfluidics Rsc Advances. 5: 88886-88889. DOI: 10.1039/C5Ra20646D |
0.346 |
|
| 2015 |
Fatouros-Bergman H, Cervenka C, Flyckt L, Edman G, Schwieler L, Ikonen P, Collste K, Piehl F, Agartz I, Engberg G, Erhardt S, Farde L. Cognitive Performance in Drug-naÏve First Episode Schizophrenia (FES) Patients European Psychiatry. 30: 277. DOI: 10.1016/S0924-9338(15)30225-X |
0.306 |
|
| 2015 |
Finnema SJ, Halldin C, Bang-Andersen B, Bundgaard C, Farde L. Serotonin transporter occupancy by escitalopram and citalopram in the non-human primate brain: a [11C]MADAM PET study Psychopharmacology. DOI: 10.1007/s00213-015-3961-7 |
0.345 |
|
| 2014 |
Fridén M, Wennerberg M, Antonsson M, Sandberg-Ställ M, Farde L, Schou M. Identification of positron emission tomography (PET) tracer candidates by prediction of the target-bound fraction in the brain. Ejnmmi Research. 4: 50. PMID 26116114 DOI: 10.1186/s13550-014-0050-6 |
0.438 |
|
| 2014 |
Nord M, Cselenyi Z, Forsberg A, Rosenqvist G, Tiger M, Lundberg J, Varrone A, Farde L. Distinct regional age effects on [11C]AZ10419369 binding to 5-HT1B receptors in the human brain. Neuroimage. 103: 303-8. PMID 25255943 DOI: 10.1016/J.Neuroimage.2014.09.040 |
0.395 |
|
| 2014 |
Plavén-Sigray P, Gustavsson P, Farde L, Borg J, Stenkrona P, Nyberg L, Bäckman L, Cervenka S. Dopamine D1 receptor availability is related to social behavior: a positron emission tomography study. Neuroimage. 102: 590-5. PMID 25134976 DOI: 10.1016/J.Neuroimage.2014.08.018 |
0.638 |
|
| 2014 |
Fatouros-Bergman H, Cervenka S, Flyckt L, Edman G, Farde L. Meta-analysis of cognitive performance in drug-naïve patients with schizophrenia. Schizophrenia Research. 158: 156-62. PMID 25086658 DOI: 10.1016/j.schres.2014.06.034 |
0.496 |
|
| 2014 |
Tiger M, Rück C, Forsberg A, Varrone A, Lindefors N, Halldin C, Farde L, Lundberg J. Reduced 5-HT(1B) receptor binding in the dorsal brain stem after cognitive behavioural therapy of major depressive disorder. Psychiatry Research. 223: 164-70. PMID 24916155 DOI: 10.1016/J.Pscychresns.2014.05.011 |
0.433 |
|
| 2014 |
Schain M, Varnäs K, Cselényi Z, Halldin C, Farde L, Varrone A. Evaluation of two automated methods for PET region of interest analysis. Neuroinformatics. 12: 551-62. PMID 24880728 DOI: 10.1007/S12021-014-9233-6 |
0.372 |
|
| 2014 |
Finnema SJ, Stepanov V, Nakao R, Sromek AW, Zhang T, Neumeyer JL, George SR, Seeman P, Stabin MG, Jonsson C, Farde L, Halldin C. (18)F-MCL-524, an (18)F-Labeled Dopamine D2 and D3 Receptor Agonist Sensitive to Dopamine: A Preliminary PET Study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1164-70. PMID 24790219 DOI: 10.2967/Jnumed.113.133876 |
0.492 |
|
| 2014 |
Ito H, Shimada H, Shinotoh H, Takano H, Sasaki T, Nogami T, Suzuki M, Nagashima T, Takahata K, Seki C, Kodaka F, Eguchi Y, Fujiwara H, Kimura Y, Hirano S, ... ... Farde L, et al. Quantitative Analysis of Amyloid Deposition in Alzheimer Disease Using PET and the Radiotracer ¹¹C-AZD2184. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 932-8. PMID 24732152 DOI: 10.2967/jnumed.113.133793 |
0.364 |
|
| 2014 |
Varrone A, Svenningsson P, Forsberg A, Varnäs K, Tiger M, Nakao R, Halldin C, Nilsson LG, Farde L. Positron emission tomography imaging of 5-hydroxytryptamine1B receptors in Parkinson's disease. Neurobiology of Aging. 35: 867-75. PMID 24126162 DOI: 10.1016/J.Neurobiolaging.2013.08.025 |
0.353 |
|
| 2014 |
Nord M, Finnema SJ, Schain M, Halldin C, Farde L. Test-retest reliability of [11C]AZ10419369 binding to 5-HT(1B) receptors in human brain. European Journal of Nuclear Medicine and Molecular Imaging. 41: 301-7. PMID 24006152 DOI: 10.1007/S00259-013-2529-1 |
0.38 |
|
| 2014 |
Schou M, Varnäs K, Sandell J, Johnström P, Cselenyi Z, Svensson S, Nakao R, Amini N, Bergman L, Sumic A, Gulyas B, Lindström-Böö E, Halldin C, Farde L. Synthesis, radiolabeling, and in vivo pharmacokinetic evaluation of the amyloid beta radioligand [11C]AZD4694 in nonhuman primates. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 16: 173-9. PMID 24002613 DOI: 10.1007/S11307-013-0666-3 |
0.709 |
|
| 2013 |
Nagy K, Tóth M, Major P, Patay G, Egri G, Häggkvist J, Varrone A, Farde L, Halldin C, Gulyás B. Performance evaluation of the small-animal nanoScan PET/MRI system. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1825-32. PMID 23990683 DOI: 10.2967/Jnumed.112.119065 |
0.626 |
|
| 2013 |
Airaksinen AJ, Finnema SJ, Balle T, Varnäs K, Bang-Andersen B, Gulyás B, Farde L, Halldin C. Radiosynthesis and evaluation of new α1-adrenoceptor antagonists as PET radioligands for brain imaging. Nuclear Medicine and Biology. 40: 747-54. PMID 23810488 DOI: 10.1016/J.Nucmedbio.2013.05.007 |
0.719 |
|
| 2013 |
Nyberg S, Jucaite A, Takano A, Kågedal M, Cselényi Z, Halldin C, Farde L. Norepinephrine transporter occupancy in the human brain after oral administration of quetiapine XR. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 2235-44. PMID 23809226 DOI: 10.1017/S1461145713000680 |
0.483 |
|
| 2013 |
Varnäs K, Varrone A, Farde L. Modeling of PET data in CNS drug discovery and development. Journal of Pharmacokinetics and Pharmacodynamics. 40: 267-79. PMID 23660778 DOI: 10.1007/S10928-013-9320-6 |
0.386 |
|
| 2013 |
Schain M, Benjaminsson S, Varnäs K, Forsberg A, Halldin C, Lansner A, Farde L, Varrone A. Arterial input function derived from pairwise correlations between PET-image voxels. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 33: 1058-65. PMID 23571279 DOI: 10.1038/Jcbfm.2013.47 |
0.36 |
|
| 2013 |
Andersson JD, Seneca N, Truong P, Wensbo D, Raboisson P, Farde L, Halldin C. Palladium mediated ¹¹C-cyanation and characterization in the non-human primate brain of the novel mGluR5 radioligand [¹¹C]AZD9272. Nuclear Medicine and Biology. 40: 547-53. PMID 23541825 DOI: 10.1016/J.Nucmedbio.2012.12.012 |
0.484 |
|
| 2013 |
Finnema SJ, Bang-Andersen B, Jørgensen M, Christoffersen CT, Gulyás B, Wikström HV, Farde L, Halldin C. The dopamine D₠receptor agonist (S)-[¹¹C]N-methyl-NNC 01-0259 is not sensitive to changes in dopamine concentration--a positron emission tomography examination in the monkey brain. Synapse (New York, N.Y.). 67: 586-95. PMID 23504964 DOI: 10.1002/syn.21664 |
0.757 |
|
| 2013 |
Varnäs K, JuÄaite A, McCarthy DJ, Stenkrona P, Nord M, Halldin C, Farde L, Kanes S. A PET study with [11C]AZ10419369 to determine brain 5-HT1B receptor occupancy of zolmitriptan in healthy male volunteers. Cephalalgia : An International Journal of Headache. 33: 853-60. PMID 23430984 DOI: 10.1177/0333102413476372 |
0.495 |
|
| 2013 |
Schou M, Varnäs K, Jucaite A, Gulyás B, Halldin C, Farde L. Radiolabeling of the cannabinoid receptor agonist AZD1940 with carbon-11 and PET microdosing in non-human primate. Nuclear Medicine and Biology. 40: 410-4. PMID 23352602 DOI: 10.1016/J.Nucmedbio.2012.10.011 |
0.725 |
|
| 2013 |
Forsberg A, Juréus A, Cselényi Z, Eriksdotter M, Freund-Levi Y, Jeppsson F, Swahn BM, Sandell J, Julin P, Schou M, Andersson J, Johnström P, Varnäs K, Halldin C, Farde L, et al. Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer's disease patients. European Journal of Nuclear Medicine and Molecular Imaging. 40: 580-93. PMID 23324871 DOI: 10.1007/S00259-012-2322-6 |
0.415 |
|
| 2013 |
Kodaka F, Ito H, Kimura Y, Fujie S, Takano H, Fujiwara H, Sasaki T, Nakayama K, Halldin C, Farde L, Suhara T. Test-retest reproducibility of dopamine D2/3 receptor binding in human brain measured by PET with [11C]MNPA and [11C]raclopride. European Journal of Nuclear Medicine and Molecular Imaging. 40: 574-9. PMID 23238524 DOI: 10.1007/S00259-012-2312-8 |
0.466 |
|
| 2013 |
de Manzano Ö, Cervenka S, Jucaite A, Hellenäs O, Farde L, Ullén F. Individual differences in the proneness to have flow experiences are linked to dopamine D2-receptor availability in the dorsal striatum. Neuroimage. 67: 1-6. PMID 23128075 DOI: 10.1016/J.Neuroimage.2012.10.072 |
0.625 |
|
| 2013 |
Takano A, Halldin C, Farde L. SERT and NET occupancy by venlafaxine and milnacipran in nonhuman primates: a PET study. Psychopharmacology. 226: 147-53. PMID 23090625 DOI: 10.1007/S00213-012-2901-Z |
0.412 |
|
| 2013 |
Schain M, Tóth M, Cselényi Z, Arakawa R, Halldin C, Farde L, Varrone A. Improved mapping and quantification of serotonin transporter availability in the human brainstem with the HRRT. European Journal of Nuclear Medicine and Molecular Imaging. 40: 228-37. PMID 23076621 DOI: 10.1007/S00259-012-2260-3 |
0.444 |
|
| 2013 |
Guterstam J, Jayaram-Lindström N, Cervenka S, Frost JJ, Farde L, Halldin C, Franck J. Effects of amphetamine on the human brain opioid system--a positron emission tomography study. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 763-9. PMID 22932428 DOI: 10.1017/S1461145712000818 |
0.649 |
|
| 2013 |
Jucaite A, Cselényi Z, Varrone A, Varnäs K, Johnström P, Halldin C, Salter H, McLoughlin M, Rinne J, Svenningsson P, Alexander R, Kugler A, Farde L. 145. Translocator protein (TSPO) as a biomarker of microglia activation: PET imaging using [11C]PBR28 in Parkinson’s disease Brain, Behavior, and Immunity. 32: e42. DOI: 10.1016/J.Bbi.2013.07.157 |
0.464 |
|
| 2012 |
Ju?aite A, Cselényi Z, Arvidsson A, Ahlberg G, Julin P, Varnäs K, Stenkrona P, Andersson J, Halldin C, Farde L. Kinetic analysis and test-retest variability of the radioligand [11C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects. Ejnmmi Research. 2: 15. PMID 22524272 DOI: 10.1186/2191-219X-2-15 |
0.427 |
|
| 2012 |
Cselényi Z, Jönhagen ME, Forsberg A, Halldin C, Julin P, Schou M, Johnström P, Varnäs K, Svensson S, Farde L. Clinical validation of 18F-AZD4694, an amyloid-β-specific PET radioligand. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 415-24. PMID 22323782 DOI: 10.2967/Jnumed.111.094029 |
0.391 |
|
| 2012 |
Lundberg J, Tiger M, Landén M, Halldin C, Farde L. Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 1167-72. PMID 22243688 DOI: 10.1017/S1461145711001945 |
0.364 |
|
| 2012 |
Schain M, Tóth M, Cselényi Z, Stenkrona P, Halldin C, Farde L, Varrone A. Quantification of serotonin transporter availability with [11C]MADAM--a comparison between the ECAT HRRT and HR systems. Neuroimage. 60: 800-7. PMID 22227138 DOI: 10.1016/J.Neuroimage.2011.12.047 |
0.361 |
|
| 2012 |
Finnema SJ, Varrone A, Hwang TJ, Halldin C, Farde L. Confirmation of fenfluramine effect on 5-HT(1B) receptor binding of [(11)C]AZ10419369 using an equilibrium approach. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 32: 685-95. PMID 22167236 DOI: 10.1038/Jcbfm.2011.172 |
0.492 |
|
| 2012 |
Odano I, Varrone A, Savic I, Ciumas C, Karlsson P, Jucaite A, Halldin C, Farde L. Quantitative PET analyses of regional [11C]PE2I binding to the dopamine transporter--application to juvenile myoclonic epilepsy. Neuroimage. 59: 3582-93. PMID 22056530 DOI: 10.1016/J.Neuroimage.2011.10.067 |
0.468 |
|
| 2012 |
Sestini S, Halldin C, Mansi L, Castagnoli A, Farde L. Pharmacokinetic analysis of plasma curves obtained after i.v. injection of the PET radioligand [11C] raclopride provides a likely explanation for rapid radioligand metabolism. Journal of Cellular Physiology. 227: 1663-9. PMID 21678422 DOI: 10.1002/Jcp.22890 |
0.425 |
|
| 2012 |
Comley RA, Cervenka S, Palhagen SE, Panagiotidis G, Matthews JC, Lai RY, Halldin C, Farde L, Nichols TE, Whitcher BJ. A comparison of gray matter density in restless legs syndrome patients and matched controls using voxel-based morphometry. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 22: 28-32. PMID 21091816 DOI: 10.1111/J.1552-6569.2010.00536.X |
0.59 |
|
| 2012 |
Guterstam J, Jayaram-Lindstrom N, Cervenka S, Halldin C, Farde L, Frost J, Franck J. P.3.004 Amphetamine-opioid interactions in the human brain reward system – a PET study using [11C]carfentanil European Neuropsychopharmacology. 22: S55. DOI: 10.1016/S0924-977X(12)70057-3 |
0.641 |
|
| 2012 |
Chen K, Langbaum J, Fleisher A, Roontiva A, Liu X, Thiyyagura P, Bandy D, Richter N, Jakimovich L, Prouty A, Cselenyi Z, Farde L, Budd S, Reiman E. IC-P-011: Amyloid PET imaging using AZD4694 and unusually brief radiotracer uptake and scanning periods Alzheimer's & Dementia. 8: P14-P14. DOI: 10.1016/j.jalz.2012.05.043 |
0.302 |
|
| 2011 |
Goodwin RJ, Mackay CL, Nilsson A, Harrison DJ, Farde L, Andren PE, Iverson SL. Qualitative and quantitative MALDI imaging of the positron emission tomography ligands raclopride (a D2 dopamine antagonist) and SCH 23390 (a D1 dopamine antagonist) in rat brain tissue sections using a solvent-free dry matrix application method. Analytical Chemistry. 83: 9694-701. PMID 22077717 DOI: 10.1021/ac202630t |
0.316 |
|
| 2011 |
Karlsson S, Rieckmann A, Karlsson P, Farde L, Nyberg L, Bäckman L. Relationship of dopamine D1 receptor binding in striatal and extrastriatal regions to cognitive functioning in healthy humans. Neuroimage. 57: 346-51. PMID 21549202 DOI: 10.1016/J.Neuroimage.2011.04.047 |
0.47 |
|
| 2011 |
Nord M, Nyberg S, Brogren J, Jucaite A, Halldin C, Farde L. Comparison of Dâ‚‚ dopamine receptor occupancy after oral administration of quetiapine fumarate immediate-release and extended-release formulations in healthy subjects. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 14: 1357-66. PMID 21477416 DOI: 10.1017/S1461145711000514 |
0.475 |
|
| 2011 |
Takano A, Nag S, Gulyás B, Halldin C, Farde L. NET occupancy by clomipramine and its active metabolite, desmethylclomipramine, in non-human primates in vivo. Psychopharmacology. 216: 279-86. PMID 21336575 DOI: 10.1007/S00213-011-2212-9 |
0.693 |
|
| 2011 |
Andersson JD, Pierson ME, Finnema SJ, Gulyás B, Heys R, Elmore CS, Farde L, Halldin C. Development of a PET radioligand for the central 5-HT1B receptor: radiosynthesis and characterization in cynomolgus monkeys of eight radiolabeled compounds. Nuclear Medicine and Biology. 38: 261-72. PMID 21315282 DOI: 10.1016/J.Nucmedbio.2010.08.006 |
0.729 |
|
| 2011 |
Rieckmann A, Karlsson S, Karlsson P, Brehmer Y, Fischer H, Farde L, Nyberg L, Bäckman L. Dopamine D1 receptor associations within and between dopaminergic pathways in younger and elderly adults: links to cognitive performance. Cerebral Cortex (New York, N.Y. : 1991). 21: 2023-32. PMID 21258043 DOI: 10.1093/Cercor/Bhq266 |
0.43 |
|
| 2011 |
Varnäs K, Nyberg S, Karlsson P, Pierson ME, Kågedal M, Cselényi Z, McCarthy D, Xiao A, Zhang M, Halldin C, Farde L. Dose-dependent binding of AZD3783 to brain 5-HT1B receptors in non-human primates and human subjects: a positron emission tomography study with [11C]AZ10419369. Psychopharmacology. 213: 533-45. PMID 21234549 DOI: 10.1007/S00213-011-2165-Z |
0.487 |
|
| 2011 |
Nord M, Farde L. Antipsychotic occupancy of dopamine receptors in schizophrenia. Cns Neuroscience & Therapeutics. 17: 97-103. PMID 21143431 DOI: 10.1111/j.1755-5949.2010.00222.x |
0.482 |
|
| 2011 |
Esmaeilzadeh M, Farde L, Karlsson P, Varrone A, Halldin C, Waters S, Tedroff J. Extrastriatal dopamine D(2) receptor binding in Huntington's disease. Human Brain Mapping. 32: 1626-36. PMID 20886576 DOI: 10.1002/Hbm.21134 |
0.521 |
|
| 2011 |
Kodaka F, Ito H, Takano H, Takahashi H, Arakawa R, Miyoshi M, Okumura M, Otsuka T, Nakayama K, Halldin C, Farde L, Suhara T. Effect of risperidone on high-affinity state of dopamine D2 receptors: a PET study with agonist ligand [11C](R)-2-CH3O-N-n-propylnorapomorphine. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 14: 83-9. PMID 20860881 DOI: 10.1017/S1461145710001148 |
0.524 |
|
| 2011 |
Varnäs K, Nyberg S, Halldin C, Varrone A, Takano A, Karlsson P, Andersson J, McCarthy D, Smith M, Pierson ME, Söderström J, Farde L. Quantitative analysis of [11C]AZ10419369 binding to 5-HT1B receptors in human brain. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 31: 113-23. PMID 20424633 DOI: 10.1038/Jcbfm.2010.55 |
0.457 |
|
| 2011 |
Bäckman L, Karlsson S, Fischer H, Karlsson P, Brehmer Y, Rieckmann A, MacDonald SW, Farde L, Nyberg L. Dopamine D(1) receptors and age differences in brain activation during working memory. Neurobiology of Aging. 32: 1849-56. PMID 19962789 DOI: 10.1016/J.Neurobiolaging.2009.10.018 |
0.411 |
|
| 2010 |
Andersson JD, Varnäs K, Cselényi Z, Gulyás B, Wensbo D, Finnema SJ, Swahn BM, Svensson S, Nyberg S, Farde L, Halldin C. Radiosynthesis of the candidate beta-amyloid radioligand [(11)C]AZD2184: Positron emission tomography examination and metabolite analysis in cynomolgus monkeys. Synapse (New York, N.Y.). 64: 733-41. PMID 20698029 DOI: 10.1002/Syn.20782 |
0.721 |
|
| 2010 |
de Manzano O, Cervenka S, Karabanov A, Farde L, Ullén F. Thinking outside a less intact box: thalamic dopamine D2 receptor densities are negatively related to psychometric creativity in healthy individuals. Plos One. 5: e10670. PMID 20498850 DOI: 10.1371/Journal.Pone.0010670 |
0.675 |
|
| 2010 |
Juréus A, Swahn BM, Sandell J, Jeppsson F, Johnson AE, Johnström P, Neelissen JA, Sunnemark D, Farde L, Svensson SP. Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand. Journal of Neurochemistry. 114: 784-94. PMID 20477945 DOI: 10.1111/j.1471-4159.2010.06812.x |
0.406 |
|
| 2010 |
Karabanov A, Cervenka S, de Manzano O, Forssberg H, Farde L, Ullén F. Dopamine D2 receptor density in the limbic striatum is related to implicit but not explicit movement sequence learning. Proceedings of the National Academy of Sciences of the United States of America. 107: 7574-9. PMID 20368439 DOI: 10.1073/Pnas.0911805107 |
0.582 |
|
| 2010 |
Finnema SJ, Varrone A, Hwang TJ, Gulyás B, Pierson ME, Halldin C, Farde L. Fenfluramine-induced serotonin release decreases [11C]AZ10419369 binding to 5-HT1B-receptors in the primate brain. Synapse (New York, N.Y.). 64: 573-7. PMID 20222157 DOI: 10.1002/Syn.20780 |
0.703 |
|
| 2010 |
Cervenka S, Varrone A, Fransén E, Halldin C, Farde L. PET studies of D2-receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans. Synapse (New York, N.Y.). 64: 478-85. PMID 20175222 DOI: 10.1002/Syn.20765 |
0.728 |
|
| 2010 |
Fischer H, Nyberg L, Karlsson S, Karlsson P, Brehmer Y, Rieckmann A, MacDonald SW, Farde L, Bäckman L. Simulating neurocognitive aging: effects of a dopaminergic antagonist on brain activity during working memory. Biological Psychiatry. 67: 575-80. PMID 20138255 DOI: 10.1016/J.Biopsych.2009.12.013 |
0.402 |
|
| 2010 |
Jucaite A, Forssberg H, Karlsson P, Halldin C, Farde L. Age-related reduction in dopamine D1 receptors in the human brain: from late childhood to adulthood, a positron emission tomography study. Neuroscience. 167: 104-10. PMID 20109534 DOI: 10.1016/J.Neuroscience.2010.01.034 |
0.494 |
|
| 2010 |
Cervenka S, Gustavsson JP, Halldin C, Farde L. Association between striatal and extrastriatal dopamine D2-receptor binding and social desirability. Neuroimage. 50: 323-8. PMID 20004254 DOI: 10.1016/J.Neuroimage.2009.12.006 |
0.674 |
|
| 2010 |
Finnema S, Varrone A, Hwang T, Farde L, Halldin C. P.1.e.021 In vivo assessment of changes in serotonin release in the non-human primate brain using PET and [11C]AZ10419369 European Neuropsychopharmacology. 20: S299-S300. DOI: 10.1016/S0924-977X(10)70399-0 |
0.411 |
|
| 2010 |
Cselényi Z, Jönhagen ME, Forsberg A, Halldin C, Julin P, Schou M, Johnström P, Varnäs K, Svensson S, Farde L. Quantification and wavelet-aided parametric imaging of cerebral amyloid using the HRRT PET-system and [18F]AZD4694 Neuroimage. 52: S142. DOI: 10.1016/J.Neuroimage.2010.04.116 |
0.319 |
|
| 2010 |
Andersson J, Seneca N, Truong P, Wensbo D, McLeod D, Raboisson P, Farde L, Halldin C. The novel mGluR5 radioligand [11C]AZ11696415: Palladium mediated 11C-cyanation and initial in vivo characterization in the cynomolgus monkey brain using positron emission tomography (PET) Neuroimage. 52: S122. DOI: 10.1016/J.Neuroimage.2010.04.100 |
0.466 |
|
| 2010 |
Kodaka F, Ito H, Takano H, Takahashi H, Arakawa R, Fujie S, Sasaki T, Nakayama K, Halldin C, Farde L, Suhara T. Regional distribution of high and low affinity states of dopamine D2/3 receptor binding in humans: A PET study using [11C]MNPA and [11C]raclopride Neuroimage. 52: S95. DOI: 10.1016/J.Neuroimage.2010.04.076 |
0.543 |
|
| 2010 |
Finnema S, Varnäs K, Stepanov V, Varrone A, Gulyás B, Arponen E, Helin S, Solin O, Haaparanta M, Sallinen J, Ingman K, Scheinin M, Farde L, Halldin C. Amphetamine decreases binding of the novel alpha2C-adrenoreceptor radioligand [11C]ORM-13070 in monkey brain Neuroimage. 52: S61-S62. DOI: 10.1016/J.Neuroimage.2010.04.047 |
0.706 |
|
| 2010 |
Finnema S, Varrone A, Hwang T, Farde L, Halldin C. Confirmation of fenfluramine effect on 5-HT1B binding of [11C]AZ10419369 using an equilibrium approach Neuroimage. 52: S55. DOI: 10.1016/J.Neuroimage.2010.04.042 |
0.346 |
|
| 2009 |
Karlsson S, Nyberg L, Karlsson P, Fischer H, Thilers P, Macdonald S, Brehmer Y, Rieckmann A, Halldin C, Farde L, Bäckman L. Modulation of striatal dopamine D1 binding by cognitive processing. Neuroimage. 48: 398-404. PMID 19539768 DOI: 10.1016/J.Neuroimage.2009.06.030 |
0.421 |
|
| 2009 |
MacDonald SW, Cervenka S, Farde L, Nyberg L, Bäckman L. Extrastriatal dopamine D2 receptor binding modulates intraindividual variability in episodic recognition and executive functioning. Neuropsychologia. 47: 2299-304. PMID 19524093 DOI: 10.1016/J.Neuropsychologia.2009.01.016 |
0.609 |
|
| 2009 |
Henningsson S, Borg J, Lundberg J, Bah J, Lindström M, Ryding E, Jovanovic H, Saijo T, Inoue M, Rosén I, Träskman-Bendz L, Farde L, Eriksson E. Genetic variation in brain-derived neurotrophic factor is associated with serotonin transporter but not serotonin-1A receptor availability in men. Biological Psychiatry. 66: 477-85. PMID 19500776 DOI: 10.1016/J.Biopsych.2009.04.009 |
0.45 |
|
| 2009 |
Nyberg S, Jönhagen ME, Cselényi Z, Halldin C, Julin P, Olsson H, Freund-Levi Y, Andersson J, Varnäs K, Svensson S, Farde L. Detection of amyloid in Alzheimer's disease with positron emission tomography using [11C]AZD2184. European Journal of Nuclear Medicine and Molecular Imaging. 36: 1859-63. PMID 19495746 DOI: 10.1007/S00259-009-1182-1 |
0.414 |
|
| 2009 |
Varrone A, Sjöholm N, Eriksson L, Gulyás B, Halldin C, Farde L. Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT. European Journal of Nuclear Medicine and Molecular Imaging. 36: 1639-50. PMID 19437012 DOI: 10.1007/S00259-009-1156-3 |
0.72 |
|
| 2009 |
Otsuka T, Ito H, Halldin C, Takahashi H, Takano H, Arakawa R, Okumura M, Kodaka F, Miyoshi M, Sekine M, Seki C, Nakao R, Suzuki K, Finnema S, Hirayasu Y, ... ... Farde L, et al. Quantitative PET analysis of the dopamine D2 receptor agonist radioligand 11C-(R)-2-CH3O-N-n-propylnorapomorphine in the human brain. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 703-10. PMID 19372485 DOI: 10.2967/Jnumed.108.058503 |
0.545 |
|
| 2009 |
Larsson M, Farde L, Hummel T, Witt M, Lindroth NE, Bäckman L. Age-related loss of olfactory sensitivity: association to dopamine transporter binding in putamen. Neuroscience. 161: 422-6. PMID 19348872 DOI: 10.1016/J.Neuroscience.2009.03.074 |
0.352 |
|
| 2009 |
McNab F, Varrone A, Farde L, Jucaite A, Bystritsky P, Forssberg H, Klingberg T. Changes in cortical dopamine D1 receptor binding associated with cognitive training. Science (New York, N.Y.). 323: 800-2. PMID 19197069 DOI: 10.1126/Science.1166102 |
0.416 |
|
| 2009 |
Finnema SJ, Halldin C, Bang-Andersen B, Gulyás B, Bundgaard C, Wikström HV, Farde L. Dopamine D(2/3) receptor occupancy of apomorphine in the nonhuman primate brain--a comparative PET study with [11C]raclopride and [11C]MNPA. Synapse (New York, N.Y.). 63: 378-89. PMID 19173265 DOI: 10.1002/Syn.20615 |
0.756 |
|
| 2009 |
Johnson AE, Jeppsson F, Sandell J, Wensbo D, Neelissen JA, Juréus A, Ström P, Norman H, Farde L, Svensson SP. AZD2184: a radioligand for sensitive detection of beta-amyloid deposits. Journal of Neurochemistry. 108: 1177-86. PMID 19141073 DOI: 10.1111/j.1471-4159.2008.05861.x |
0.366 |
|
| 2009 |
Odano I, Halldin C, Karlsson P, Varrone A, Airaksinen AJ, Krasikova RN, Farde L. [18F]flumazenil binding to central benzodiazepine receptor studies by PET--quantitative analysis and comparisons with [11C]flumazenil. Neuroimage. 45: 891-902. PMID 19136064 DOI: 10.1016/J.Neuroimage.2008.12.005 |
0.458 |
|
| 2009 |
Borg J, Henningsson S, Saijo T, Inoue M, Bah J, Westberg L, Lundberg J, Jovanovic H, Andrée B, Nordstrom AL, Halldin C, Eriksson E, Farde L. Serotonin transporter genotype is associated with cognitive performance but not regional 5-HT1A receptor binding in humans. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 12: 783-92. PMID 19126263 DOI: 10.1017/S1461145708009759 |
0.425 |
|
| 2009 |
Schou M, Zoghbi SS, Shetty HU, Shchukin E, Liow JS, Hong J, Andrée BA, Gulyás B, Farde L, Innis RB, Pike VW, Halldin C. Investigation of the metabolites of (S,S)-[(11)C]MeNER in humans, monkeys and rats. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 11: 23-30. PMID 18800204 DOI: 10.1007/S11307-008-0175-Y |
0.682 |
|
| 2009 |
Cervenka S, Halldin C, Farde L. P.1.06 Limbic dopamine D2-receptor binding and social desirability European Neuropsychopharmacology. 19: S7-S8. DOI: 10.1016/S0924-977X(09)70009-4 |
0.658 |
|
| 2009 |
Sundgren-Andersson AK, Svensson SP, Swahn B, Juréus A, Sandell J, Johnson AE, Jeppsson F, Neelissen JA, Halldin C, Johnström P, Schou M, Cselényi Z, Farde L. P2-023: AZD4694: Fluorinated Positron Emission Tomography (PET) radioligand for detection of β-amyloid deposits Alzheimer's & Dementia. 5: P267-P268. DOI: 10.1016/J.Jalz.2009.04.332 |
0.33 |
|
| 2008 |
Airaksinen AJ, Nag S, Finnema SJ, Mukherjee J, Chattopadhyay S, Gulyás B, Farde L, Halldin C. [11C]cyclopropyl-FLB 457: a PET radioligand for low densities of dopamine D2 receptors. Bioorganic & Medicinal Chemistry. 16: 6467-73. PMID 18534857 DOI: 10.1016/J.Bmc.2008.05.039 |
0.764 |
|
| 2008 |
Pierson ME, Andersson J, Nyberg S, McCarthy DJ, Finnema SJ, Varnäs K, Takano A, Karlsson P, Gulyás B, Medd AM, Lee CM, Powell ME, Heys JR, Potts W, Seneca N, ... ... Farde L, et al. [11C]AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain. Neuroimage. 41: 1075-85. PMID 18434202 DOI: 10.1016/J.Neuroimage.2008.02.063 |
0.732 |
|
| 2008 |
Cervenka S, Bäckman L, Cselényi Z, Halldin C, Farde L. Associations between dopamine D2-receptor binding and cognitive performance indicate functional compartmentalization of the human striatum. Neuroimage. 40: 1287-95. PMID 18296072 DOI: 10.1016/J.Neuroimage.2007.12.063 |
0.675 |
|
| 2008 |
Cervenka S, Halldin C, Farde L. Age-related diurnal effect on D2 receptor binding: a preliminary PET study. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 11: 671-8. PMID 18184446 DOI: 10.1017/S1461145707008358 |
0.699 |
|
| 2008 |
Hirvonen J, Johansson J, Teräs M, Oikonen V, Lumme V, Virsu P, Roivainen A, Någren K, Halldin C, Farde L, Hietala J. Measurement of striatal and extrastriatal dopamine transporter binding with high-resolution PET and [11C]PE2I: quantitative modeling and test-retest reproducibility. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 28: 1059-69. PMID 18183028 DOI: 10.1038/Sj.Jcbfm.9600607 |
0.512 |
|
| 2008 |
Nordstrom AL, Mansson M, Jovanovic H, Karlsson P, Halldin C, Farde L, Vanover KE, Hacksell U, Brann MR, Davis RE, Weiner DM. PET analysis of the 5-HT2A receptor inverse agonist ACP-103 in human brain. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 11: 163-71. PMID 17708779 DOI: 10.1017/S1461145707007869 |
0.466 |
|
| 2008 |
Nyberg S, Takano A, Jucaite A, Karlsson P, McCarthy D, Kågedal M, Eriksson H, Lee C, Halldin C, Farde L. P.1.e.019 PET-measured occupancy of the norepinephrene transporter by extended release quetiapine fumarate (quetiapine XR) in brains of healthy subjects European Neuropsychopharmacology. 18: S270. DOI: 10.1016/S0924-977X(08)70352-3 |
0.361 |
|
| 2008 |
Jovanovic H, Andersson E, Karlsson P, Halldin C, Nordstöm A, Åsberg M, Farde L. P.3.24 Lower 5-HT1A receptor binding in patients with borderline personality disorder: a PET study using [11C]WAY100635 European Neuropsychopharmacology. 18: s82-s83. DOI: 10.1016/S0924-977X(08)70095-6 |
0.438 |
|
| 2008 |
Borg J, Lundberg J, Andrée B, Kizling I, Halldin C, Farde L. P.3.02 Molecular imaging of the 5-HT1A receptor and 5-HTT in relation to cognitive functions in man European Neuropsychopharmacology. 18: s64. DOI: 10.1016/S0924-977X(08)70073-7 |
0.305 |
|
| 2008 |
Finnema SJ, Bang-Andersen B, Gulyás B, Bundgaard C, Wikström H, Halldin C, Farde L. Dopamine D2/3 receptor occupancy of apomorphine in the non-human primate brain does not support the existence of two affinity states in vivo Neuroimage. 41: T38. DOI: 10.1016/j.neuroimage.2008.04.212 |
0.489 |
|
| 2008 |
Otsuka T, Ito H, Takahashi H, Takano H, Arakawa R, Okumura M, Kodaka F, Miyoshi M, Sekine M, Seki C, Suhara T, Halldin C, Farde L. Quantitative analysis of dopamine D2 receptor binding in human brain using PET with an agonist radioligand [11C]MNPA Neuroimage. 41: T134. DOI: 10.1016/J.Neuroimage.2008.04.102 |
0.591 |
|
| 2008 |
Steiger C, Finnema S, Wikström H, Gulyás B, Nakao R, Suzuki K, Farde L, Halldin C. Radiosynthesis of [11C]MNPA from the precursor (R)-(−)-2-hydroxy-10,11-acetonide-NPA and a preliminary test–retest PET analysis in monkey brain Neuroimage. 41: T102. DOI: 10.1016/j.neuroimage.2008.04.071 |
0.688 |
|
| 2008 |
Varrone A, Sjoholm N, Gulyas B, Halldin C, Farde L. Advancement in PET quantification using 3D-OP-OSEM PSF reconstruction with the HRRT Neuroimage. 41: T85. DOI: 10.1016/J.Neuroimage.2008.04.054 |
0.667 |
|
| 2008 |
Odano I, Sakaguchi K, Hosoya T, Varrone A, Savic I, Halldin C, Farde L. Automated system for parametric image analysis in neuroreceptor binding studies with PET Neuroimage. 41: T77. DOI: 10.1016/J.Neuroimage.2008.04.047 |
0.376 |
|
| 2007 |
Lundberg J, Borg J, Halldin C, Farde L. A PET study on regional coexpression of 5-HT1A receptors and 5-HTT in the human brain. Psychopharmacology. 195: 425-33. PMID 17874074 DOI: 10.1007/S00213-007-0928-3 |
0.484 |
|
| 2007 |
Lundberg J, Christophersen JS, Petersen KB, Loft H, Halldin C, Farde L. PET measurement of serotonin transporter occupancy: a comparison of escitalopram and citalopram. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 10: 777-85. PMID 17201996 DOI: 10.1017/S1461145706007486 |
0.403 |
|
| 2007 |
Schou M, Pike VW, Sóvágó J, Gulyás B, Gallagher PT, Dobson DR, Walter MW, Rudyk H, Farde L, Halldin C. Synthesis of 11C-labelled (R)-OHDMI and CFMME and their evaluation as candidate radioligands for imaging central norepinephrine transporters with PET. Bioorganic & Medicinal Chemistry. 15: 616-25. PMID 17123820 DOI: 10.1016/J.Bmc.2006.10.065 |
0.722 |
|
| 2007 |
Montgomery AJ, Asselin MC, Farde L, Grasby PM. Measurement of methylphenidate-induced change in extrastriatal dopamine concentration using [11C]FLB 457 PET. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 27: 369-77. PMID 16685253 DOI: 10.1038/sj.jcbfm.9600339 |
0.527 |
|
| 2007 |
Karlsson P, Hargarter L, Dencker E, Nyberg S, Mannaert E, Boom S, Talluri K, Rossenu S, Eriksson B, Eerdekens M, Farde L. Pharmacokinetics and dopamine d2 and serotonin 5-ht2a receptor occupancy of paliperidone in healthy subjects: two open-label, single-dose studies (PAL-115) Pharmacopsychiatry. 40. DOI: 10.1055/S-2007-991781 |
0.327 |
|
| 2007 |
Nyberg S, Takano A, Grimm S, Gulyas B, McCarthy D, Lee C, Goldstein J, Halldin C, Farde L. P.1.c.022 PET-measured D2, 5-HT2, and norepinephrine transporter (NET) occupancy by quetiapine and N-desalkyl-quetiapine in non-human primates European Neuropsychopharmacology. 17: S254-S255. DOI: 10.1016/S0924-977X(07)70346-2 |
0.403 |
|
| 2007 |
Finnema S, Bang-Andersen B, Farde L, Jorgensen M, Gulyas B, Foged C, Wikstrom H, Halldin C. A preliminary characterisation of a dopamine d1 partial agonist radioligand for pet Journal of Cerebral Blood Flow and Metabolism. 27: PP04-02M. |
0.379 |
|
| 2006 |
Talvik M, Nordström AL, Okubo Y, Olsson H, Borg J, Halldin C, Farde L. Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomography. Psychiatry Research. 148: 165-73. PMID 17095199 DOI: 10.1016/J.Pscychresns.2006.05.009 |
0.477 |
|
| 2006 |
Bäckman L, Nyberg L, Lindenberger U, Li SC, Farde L. The correlative triad among aging, dopamine, and cognition: current status and future prospects. Neuroscience and Biobehavioral Reviews. 30: 791-807. PMID 16901542 DOI: 10.1016/J.Neubiorev.2006.06.005 |
0.319 |
|
| 2006 |
Seneca N, Gulyás B, Varrone A, Schou M, Airaksinen A, Tauscher J, Vandenhende F, Kielbasa W, Farde L, Innis RB, Halldin C. Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2. Psychopharmacology. 188: 119-27. PMID 16896954 DOI: 10.1007/s00213-006-0483-3 |
0.705 |
|
| 2006 |
Cselényi Z, Olsson H, Halldin C, Gulyás B, Farde L. A comparison of recent parametric neuroreceptor mapping approaches based on measurements with the high affinity PET radioligands [11C]FLB 457 and [11C]WAY 100635. Neuroimage. 32: 1690-708. PMID 16859930 DOI: 10.1016/J.Neuroimage.2006.02.053 |
0.696 |
|
| 2006 |
Cervenka S, Pålhagen SE, Comley RA, Panagiotidis G, Cselényi Z, Matthews JC, Lai RY, Halldin C, Farde L. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain : a Journal of Neurology. 129: 2017-28. PMID 16816393 DOI: 10.1093/Brain/Awl163 |
0.7 |
|
| 2006 |
Lundberg J, Halldin C, Farde L. Measurement of serotonin transporter binding with PET and [11C]MADAM: a test-retest reproducibility study. Synapse (New York, N.Y.). 60: 256-63. PMID 16752362 DOI: 10.1002/Syn.20297 |
0.458 |
|
| 2006 |
Lee CM, Farde L. Using positron emission tomography to facilitate CNS drug development. Trends in Pharmacological Sciences. 27: 310-6. PMID 16678917 DOI: 10.1016/j.tips.2006.04.004 |
0.412 |
|
| 2006 |
Borg J, Andrée B, Lundberg J, Halldin C, Farde L. Search for correlations between serotonin 5-HT1A receptor expression and cognitive functions--a strategy in translational psychopharmacology. Psychopharmacology. 185: 389-94. PMID 16541245 DOI: 10.1007/S00213-006-0329-Z |
0.391 |
|
| 2006 |
Jucaite A, Odano I, Olsson H, Pauli S, Halldin C, Farde L. Quantitative analyses of regional [11C]PE2I binding to the dopamine transporter in the human brain: a PET study. European Journal of Nuclear Medicine and Molecular Imaging. 33: 657-68. PMID 16514530 DOI: 10.1007/S00259-005-0027-9 |
0.509 |
|
| 2006 |
Seneca N, Finnema SJ, Farde L, Gulyás B, Wikström HV, Halldin C, Innis RB. Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride. Synapse (New York, N.Y.). 59: 260-9. PMID 16416444 DOI: 10.1002/Syn.20238 |
0.754 |
|
| 2006 |
Chou YH, Halldin C, Farde L. Clozapine binds preferentially to cortical D1-like dopamine receptors in the primate brain: a PET study. Psychopharmacology. 185: 29-35. PMID 16395606 DOI: 10.1007/S00213-005-0219-9 |
0.551 |
|
| 2006 |
Schou M, Sóvágó J, Pike VW, Gulyás B, Bøgesø KP, Farde L, Halldin C. Synthesis and positron emission tomography evaluation of three norepinephrine transporter radioligands: [C-11]desipramine, [C-11]talopram and [C-11]talsupram. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 8: 1-8. PMID 16322935 DOI: 10.1007/S11307-005-0027-Y |
0.724 |
|
| 2006 |
Bjerkenstedt L, Farde L, Terenius L, Edman G, Venizelos N, Wiesel FA. Support for limited brain availability of tyrosine in patients with schizophrenia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 9: 247-55. PMID 15972118 DOI: 10.1017/S1461145705005638 |
0.348 |
|
| 2006 |
Finnema S, Bang-Andersen B, Farde L, Gulyás B, Wikström H, Halldin C. Dopamine D2/D3 receptor occupancy of apomorphine evaluated with the agonist radioligand [11C]MNPA and the antagonist radioligand [11C]Raclopride. A PET evaluation in the non-human primate brain Neuroimage. 31: T120. DOI: 10.1016/J.Neuroimage.2006.04.106 |
0.554 |
|
| 2006 |
Finnema S, Bang-Andersen B, Farde L, Jørgensen M, Gulyás B, Foged C, Wikström H, Halldin C. PET evaluation of the partial dopamine D1 receptor agonist radioligands R- and S-[11C]N-Methyl-NNC 01-0259 Neuroimage. 31: T114. DOI: 10.1016/J.Neuroimage.2006.04.100 |
0.493 |
|
| 2006 |
Odano I, Farde L, Savic I, Ciumas C, Krasikova R, Airaksinen A, Karlsson P, Pauli S, Halldin C. Comparisons of central benzodiazepine receptor mapping tracers [18F]Flumazenil and [11C]Flumazenil presentation Neuroimage. 31: T88. DOI: 10.1016/J.Neuroimage.2006.04.076 |
0.376 |
|
| 2006 |
Odano I, Jucaite A, Olsson H, Karlsson P, Pauli S, Halldin C, Farde L. Dopamine transporter binding corrected for tissue heterogeneity and partial volume effect using [11C]PE2I and PET Neuroimage. 31: T87. DOI: 10.1016/J.Neuroimage.2006.04.075 |
0.458 |
|
| 2006 |
Sovago J, Farde L, Cervenka S, Halldin C, Gulyas B. Increasing the accuracy of in vivo quantification of dopamine-D2/D3 receptor binding in the human brain by partial volume effect correction Neuroimage. 31: T85. DOI: 10.1016/J.Neuroimage.2006.04.073 |
0.799 |
|
| 2006 |
Schou M, Pike V, Sóvágó J, Gulyás B, Gallagher P, Dobson D, Walter M, Rudyk H, Farde L, Halldin C. Synthesis of 11C-labeled (S,S)-CFMME and (R)-OHDMI and their evaluation as candidate radioligands for imaging norepinephrine transporters with PET Neuroimage. 31: T48. DOI: 10.1016/j.neuroimage.2006.04.039 |
0.664 |
|
| 2006 |
KARLSSON P, DENCKER E, NYBERG S, MANNAERT E, BOOM S, TALLURI K, ROSSENU S, ERIKSSON B, EERDEKENS M, FARDE L. PIII-57Pharmacokinetics and dopamine D2 And serotonin 5-HT2A receptor occupancy of paliperidone in healthy subjects: Two open-label, single-dose studies Clinical Pharmacology & Therapeutics. 79: P74-P74. DOI: 10.1016/j.clpt.2005.12.265 |
0.327 |
|
| 2006 |
Schou M, Pike VW, Varrone A, Gulyás B, Farde L, Halldin C. Synthesis and PET evaluation of (R)-[S-methyl-11C] thionisoxetine, a candidate radioligand for imaging brain norepinephrine transporters Journal of Labelled Compounds and Radiopharmaceuticals. 49: 1007-1019. DOI: 10.1002/Jlcr.1128 |
0.69 |
|
| 2005 |
Lundberg J, Odano I, Olsson H, Halldin C, Farde L. Quantification of 11C-MADAM binding to the serotonin transporter in the human brain. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 46: 1505-15. PMID 16157534 |
0.333 |
|
| 2005 |
Sóvágó J, Farde L, Halldin C, Schukin E, Schou M, Laszlovszky I, Kiss B, Gulyás B. Lack of effect of reserpine-induced dopamine depletion on the binding of the dopamine-D3 selective radioligand, [11C]RGH-1756. Brain Research Bulletin. 67: 219-24. PMID 16144658 DOI: 10.1016/J.Brainresbull.2005.06.034 |
0.774 |
|
| 2005 |
Schou M, Halldin C, Pike VW, Mozley PD, Dobson D, Innis RB, Farde L, Hall H. Post-mortem human brain autoradiography of the norepinephrine transporter using (S,S)-[18F]FMeNER-D2. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 15: 517-20. PMID 16139169 DOI: 10.1016/J.Euroneuro.2005.01.007 |
0.428 |
|
| 2005 |
Halldin C, Lundberg J, Sóvágó J, Gulyás B, Guilloteau D, Vercouillie J, Emond P, Chalon S, Tarkiainen J, Hiltunen J, Farde L. [(11)C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET. Synapse (New York, N.Y.). 58: 173-83. PMID 16138320 DOI: 10.1002/Syn.20189 |
0.729 |
|
| 2005 |
Meschaks A, Lindstrom P, Halldin C, Farde L, Savic I. Regional reductions in serotonin 1A receptor binding in juvenile myoclonic epilepsy. Archives of Neurology. 62: 946-50. PMID 15956165 DOI: 10.1001/Archneur.62.6.946 |
0.394 |
|
| 2005 |
McCarron JA, Marchais-Oberwinkler S, Pike VW, Tarkiainen J, Halldin C, Sóvagó J, Gulyas B, Wikström HV, Farde L. Two C-methyl derivatives of [11C]WAY-100635--effects of an amido alpha-methyl group on metabolism and brain 5-HT1A receptor radioligand behavior in monkey. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 7: 209-19. PMID 15912425 DOI: 10.1007/S11307-005-4127-5 |
0.73 |
|
| 2005 |
Finnema SJ, Seneca N, Farde L, Shchukin E, Sóvágó J, Gulyás B, Wikström HV, Innis RB, Neumeyer JL, Halldin C. A preliminary PET evaluation of the new dopamine D2 receptor agonist [11C]MNPA in cynomolgus monkey. Nuclear Medicine and Biology. 32: 353-60. PMID 15878504 DOI: 10.1016/J.Nucmedbio.2005.01.007 |
0.727 |
|
| 2005 |
Gulyás B, Halldin C, Vas A, Banati RB, Shchukin E, Finnema S, Tarkainen J, Tihanyi K, Szilágyi G, Farde L. [11C]vinpocetine: a prospective peripheral benzodiazepine receptor ligand for primate PET studies. Journal of the Neurological Sciences. 229: 219-23. PMID 15760643 DOI: 10.1016/J.Jns.2004.11.032 |
0.736 |
|
| 2005 |
Erixon-Lindroth N, Farde L, Wahlin TB, Sovago J, Halldin C, Bäckman L. The role of the striatal dopamine transporter in cognitive aging. Psychiatry Research. 138: 1-12. PMID 15708296 DOI: 10.1016/J.Pscychresns.2004.09.005 |
0.31 |
|
| 2005 |
Jucaite A, Fernell E, Halldin C, Forssberg H, Farde L. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity. Biological Psychiatry. 57: 229-38. PMID 15691523 DOI: 10.1016/J.Biopsych.2004.11.009 |
0.406 |
|
| 2005 |
Marchais-Oberwinkler S, Nowicki B, Pike VW, Halldin C, Sandell J, Chou YH, Gulyas B, Brennum LT, Farde L, Wikström HV. N-oxide analogs of WAY-100635: new high affinity 5-HT(1A) receptor antagonists. Bioorganic & Medicinal Chemistry. 13: 883-93. PMID 15653354 DOI: 10.1016/J.Bmc.2004.10.033 |
0.688 |
|
| 2005 |
Olsson H, Farde L. Half-life of receptor occupancy--a meaningless concept. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 8: 141-2. PMID 15482631 DOI: 10.1017/S1461145704004766 |
0.355 |
|
| 2005 |
Seneca N, Finnema S, Ichise M, Gulyas B, Wikstrom H, Innis RB, Farde L, Halldin C. Effect of amphetamine on dopamine D2 receptor binding in the primate brain with the agonist ligand [11C]MNPA Journal of Cerebral Blood Flow & Metabolism. 25: S646-S646. DOI: 10.1038/Sj.Jcbfm.9591524.0646 |
0.751 |
|
| 2004 |
Halldin C, Gulyás B, Farde L. PET for drug development. Ernst Schering Research Foundation Workshop. 95-109. PMID 15248518 |
0.611 |
|
| 2004 |
Cselényi Z, Lundberg J, Halldin C, Farde L, Gulyás B. Joint explorative analysis of neuroreceptor subsystems in the human brain: application to receptor-transporter correlation using PET data. Neurochemistry International. 45: 773-81. PMID 15234122 DOI: 10.1016/J.Neuint.2003.12.005 |
0.707 |
|
| 2004 |
Sóvágó J, Farde L, Halldin C, Langer O, Laszlovszky I, Kiss B, Gulyás B. Positron emission tomographic evaluation of the putative dopamine-D3 receptor ligand, [11C]RGH-1756 in the monkey brain. Neurochemistry International. 45: 609-17. PMID 15234102 DOI: 10.1016/J.Neuint.2004.04.004 |
0.779 |
|
| 2004 |
Olsson H, Halldin C, Farde L. Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET. Neuroimage. 22: 794-803. PMID 15193608 DOI: 10.1016/J.Neuroimage.2004.02.002 |
0.521 |
|
| 2004 |
Schou M, Halldin C, Sóvágó J, Pike VW, Hall H, Gulyás B, Mozley PD, Dobson D, Shchukin E, Innis RB, Farde L. PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain. Synapse (New York, N.Y.). 53: 57-67. PMID 15170818 DOI: 10.1002/Syn.20031 |
0.676 |
|
| 2004 |
Yasuno F, Suhara T, Okubo Y, Sudo Y, Inoue M, Ichimiya T, Takano A, Nakayama K, Halldin C, Farde L. Low dopamine d(2) receptor binding in subregions of the thalamus in schizophrenia. The American Journal of Psychiatry. 161: 1016-22. PMID 15169689 DOI: 10.1176/Appi.Ajp.161.6.1016 |
0.455 |
|
| 2004 |
Savic I, Lindström P, Gulyás B, Halldin C, Andrée B, Farde L. Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy. Neurology. 62: 1343-51. PMID 15111672 DOI: 10.1212/01.Wnl.0000123696.98166.Af |
0.661 |
|
| 2004 |
Damberg M, Berggård C, Farde L, Sedvall GC, Jönsson EG. Transcription factor AP-2beta genotype, striatal dopamine D2 receptor density and cerebrospinal fluid monoamine metabolite concentrations in humans. Journal of Neural Transmission (Vienna, Austria : 1996). 111: 537-45. PMID 15057523 DOI: 10.1007/s00702-003-0097-4 |
0.549 |
|
| 2004 |
Balle T, Halldin C, Andersen L, Hjorth Alifrangis L, Badolo L, Gjervig Jensen K, Chou YW, Andersen K, Perregaard J, Farde L. New alpha(1)-adrenoceptor antagonists derived from the antipsychotic sertindole - carbon-11 labelling and pet examination of brain uptake in the cynomolgus monkey. Nuclear Medicine and Biology. 31: 327-36. PMID 15028245 DOI: 10.1016/J.Nucmedbio.2003.08.012 |
0.465 |
|
| 2004 |
McCarron JA, Pike VW, Halldin C, Sandell J, Sóvágó J, Gulyas B, Cselényi Z, Wikström HV, Marchais-Oberwinkler S, Nowicki B, Dollé F, Farde L. The pyridinyl-6 position of WAY-100635 as a site for radiofluorination--effect on 5-HT1A receptor radioligand behavior in vivo. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 6: 17-26. PMID 15018825 DOI: 10.1016/J.Mibio.2003.12.001 |
0.691 |
|
| 2004 |
Talvik M, Nordström AL, Larsen NE, Jucaite A, Cervenka S, Halldin C, Farde L. A cross-validation study on the relationship between central D2 receptor occupancy and serum perphenazine concentration. Psychopharmacology. 175: 148-53. PMID 15007534 DOI: 10.1007/S00213-004-1802-1 |
0.657 |
|
| 2003 |
Talvik M, Nordström AL, Olsson H, Halldin C, Farde L. Decreased thalamic D2/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 6: 361-70. PMID 14604451 DOI: 10.1017/S1461145703003699 |
0.461 |
|
| 2003 |
Borg J, Andrée B, Soderstrom H, Farde L. The serotonin system and spiritual experiences. The American Journal of Psychiatry. 160: 1965-9. PMID 14594742 DOI: 10.1176/appi.ajp.160.11.1965 |
0.381 |
|
| 2003 |
Pike VW, Halldin C, Nobuhara K, Hiltunen J, Mulligan RS, Swahn CG, Karlsson P, Olsson H, Hume SP, Hirani E, Whalley J, Pilowsky LS, Larsson S, Schnell PO, Ell PJ, ... Farde L, et al. Radioiodinated SB 207710 as a radioligand in vivo: imaging of brain 5-HT4 receptors with SPET. European Journal of Nuclear Medicine and Molecular Imaging. 30: 1520-8. PMID 14579092 DOI: 10.1007/S00259-003-1307-X |
0.461 |
|
| 2003 |
Schou M, Halldin C, Sóvágó J, Pike VW, Gulyás B, Mozley PD, Johnson DP, Hall H, Innis RB, Farde L. Specific in vivo binding to the norepinephrine transporter demonstrated with the PET radioligand, (S,S)-[11C]MeNER. Nuclear Medicine and Biology. 30: 707-14. PMID 14499328 DOI: 10.1016/S0969-8051(03)00079-9 |
0.692 |
|
| 2003 |
Carmine A, Buervenich S, Galter D, Jönsson EG, Sedvall GC, Farde L, Gustavsson JP, Bergman H, Chowdari KV, Nimgaonkar VL, Anvret M, Sydow O, Olson L. NURR1 promoter polymorphisms: Parkinson's disease, schizophrenia, and personality traits. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 120: 51-7. PMID 12815740 DOI: 10.1002/Ajmg.B.20033 |
0.469 |
|
| 2003 |
Halldin C, Erixon-Lindroth N, Pauli S, Chou YH, Okubo Y, Karlsson P, Lundkvist C, Olsson H, Guilloteau D, Emond P, Farde L. [(11)C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain. European Journal of Nuclear Medicine and Molecular Imaging. 30: 1220-30. PMID 12811422 DOI: 10.1007/S00259-003-1212-3 |
0.5 |
|
| 2003 |
Jönsson EG, Cichon S, Gustavsson JP, Grünhage F, Forslund K, Mattila-Evenden M, Rylander G, Asberg M, Farde L, Propping P, Nöthen MM. Association between a promoter dopamine D2 receptor gene variant and the personality trait detachment. Biological Psychiatry. 53: 577-84. PMID 12679235 DOI: 10.1016/S0006-3223(02)01732-8 |
0.386 |
|
| 2003 |
Andrée B, Hedman A, Thorberg SO, Nilsson D, Halldin C, Farde L. Positron emission tomographic analysis of dose-dependent NAD-299 binding to 5-hydroxytryptamine-1A receptors in the human brain. Psychopharmacology. 167: 37-45. PMID 12632244 DOI: 10.1007/S00213-002-1355-0 |
0.394 |
|
| 2003 |
Carmine A, Chheda MG, Jönsson EG, Sedvall GC, Farde L, Gustavsson JP, Bergman H, Anvret M, Buervenich S, Olson L. Two NOTCH4 polymorphisms and their relation to schizophrenia susceptibility and different personality traits. Psychiatric Genetics. 13: 23-8. PMID 12605097 DOI: 10.1097/01.ypg.0000056680.82896.22 |
0.506 |
|
| 2003 |
Chou YH, Halldin C, Farde L. Occupancy of 5-HT1A receptors by clozapine in the primate brain: a PET study. Psychopharmacology. 166: 234-40. PMID 12589516 DOI: 10.1007/S00213-002-1256-2 |
0.44 |
|
| 2003 |
Chalon S, Tarkiainen J, Garreau L, Hall H, Emond P, Vercouillie J, Farde L, Dasse P, Varnas K, Besnard JC, Halldin C, Guilloteau D. Pharmacological characterization of N,N-dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a ligand of the serotonin transporter with high affinity and selectivity. The Journal of Pharmacology and Experimental Therapeutics. 304: 81-7. PMID 12490578 DOI: 10.1124/Jpet.102.042226 |
0.378 |
|
| 2003 |
Talvik M, Nordström A, Olsson H, Halldin C, Farde L. P.2.115 PET examinations or thalamic D2 receptors in schizophrenic patients European Neuropsychopharmacology. 13: S330. DOI: 10.1016/S0924-977X(03)92068-2 |
0.446 |
|
| 2003 |
Farde L. S.06.03 Is dopamine a variable in PET-studies on drug induced receptor occupancy? European Neuropsychopharmacology. 13: S109-S110. DOI: 10.1016/S0924-977X(03)91622-1 |
0.346 |
|
| 2002 |
Vas A, Sóvágó J, Halldin C, Sandell J, Karlsson P, Kárpáti E, Kiss B, Cselényi Z, Farde L, Gulyás B. [Cerebral uptake and regional distribution of [11C]-vinpocetin after intravenous administration to healthy men: a PET study]. Orvosi Hetilap. 143: 2631-6. PMID 12532649 |
0.684 |
|
| 2002 |
Cselényi Z, Olsson H, Farde L, Gulyás B. Wavelet-aided parametric mapping of cerebral dopamine D2 receptors using the high affinity PET radioligand [11C]FLB 457. Neuroimage. 17: 47-60. PMID 12482067 DOI: 10.1006/nimg.2002.1152 |
0.694 |
|
| 2002 |
Gulyás B, Halldin C, Sandell J, Karlsson P, Sóvágó J, Kárpáti E, Kiss B, Vas A, Cselényi Z, Farde L. PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects. Acta Neurologica Scandinavica. 106: 325-32. PMID 12460136 DOI: 10.1034/J.1600-0404.2002.01302.X |
0.701 |
|
| 2002 |
Gulyás B, Vas A, Halldin C, Sóvágó J, Sandell J, Olsson H, Fredriksson A, Stone-Elander S, Farde L. Cerebral uptake of [ethyl-11C]vinpocetine and 1-[11C]ethanol in cynomolgous monkeys: a comparative preclinical PET study. Nuclear Medicine and Biology. 29: 753-9. PMID 12381455 DOI: 10.1016/S0969-8051(02)00319-0 |
0.673 |
|
| 2002 |
Sandell J, Halldin C, Sovago J, Chou YH, Gulyás B, Yu M, Emond P, Någren K, Guilloteau D, Farde L. PET examination of [(11)C]5-methyl-6-nitroquipazine, a radioligand for visualization of the serotonin transporter. Nuclear Medicine and Biology. 29: 651-6. PMID 12234589 DOI: 10.1016/S0969-8051(02)00318-9 |
0.715 |
|
| 2002 |
Gulyás B, Halldin C, Sóvágó J, Sandell J, Cselényi Z, Vas A, Kiss B, Kárpáti E, Farde L. Drug distribution in man: a positron emission tomography study after oral administration of the labelled neuroprotective drug vinpocetine. European Journal of Nuclear Medicine and Molecular Imaging. 29: 1031-8. PMID 12173017 DOI: 10.1007/S00259-002-0823-4 |
0.679 |
|
| 2002 |
Nyberg S, Olsson H, Nilsson U, Maehlum E, Halldin C, Farde L. Low striatal and extra-striatal D2 receptor occupancy during treatment with the atypical antipsychotic sertindole. Psychopharmacology. 162: 37-41. PMID 12107615 DOI: 10.1007/S00213-002-1083-5 |
0.509 |
|
| 2002 |
Hall H, Varnäs K, Sandell J, Halldin C, Farde L, Vas A, Kárpáti E, Gulyás B. Autoradiographic evaluation of [11C]vinpocetine binding in the human postmortem brain. Acta Biologica Hungarica. 53: 59-66. PMID 12064779 DOI: 10.1556/ABiol.53.2002.1-2.7 |
0.712 |
|
| 2002 |
Karlsson P, Farde L, Halldin C, Sedvall G. PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia. The American Journal of Psychiatry. 159: 761-7. PMID 11986129 DOI: 10.1176/Appi.Ajp.159.5.761 |
0.658 |
|
| 2002 |
Andrée B, Halldin C, Pike VW, Gunn RN, Olsson H, Farde L. The PET radioligand [carbonyl-(11)C]desmethyl-WAY-100635 binds to 5-HT(1A) receptors and provides a higher radioactive signal than [carbonyl-(11)C]WAY-100635 in the human brain. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 43: 292-303. PMID 11884487 |
0.378 |
|
| 2002 |
Sandell J, Halldin C, Chou YH, Swahn CG, Thorberg SO, Farde L. PET-examination and metabolite evaluation in monkey of [(11)C]NAD-299, a radioligand for visualisation of the 5-HT(1A) receptor. Nuclear Medicine and Biology. 29: 39-45. PMID 11786274 DOI: 10.1016/S0969-8051(01)00272-4 |
0.45 |
|
| 2002 |
Suhara T, Okubo Y, Yasuno F, Sudo Y, Inoue M, Ichimiya T, Nakashima Y, Nakayama K, Tanada S, Suzuki K, Halldin C, Farde L. Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia. Archives of General Psychiatry. 59: 25-30. PMID 11779278 DOI: 10.1001/Archpsyc.59.1.25 |
0.421 |
|
| 2002 |
Farde L. PET imaging of brain neurotransmission European Psychiatry. 17. DOI: 10.1016/S0924-9338(02)85016-7 |
0.392 |
|
| 2001 |
Halldin C, Gulyás B, Farde L. PET studies with carbon-11 radioligands in neuropsychopharmacological drug development. Current Pharmaceutical Design. 7: 1907-29. PMID 11772357 DOI: 10.2174/1381612013396871 |
0.677 |
|
| 2001 |
Sudo Y, Suhara T, Inoue M, Ito H, Suzuki K, Saijo T, Halldin C, Farde L. Reproducibility of [11 C]FLB 457 binding in extrastriatal regions. Nuclear Medicine Communications. 22: 1215-21. PMID 11606887 DOI: 10.1097/00006231-200111000-00008 |
0.418 |
|
| 2001 |
Olsson H, Farde L. Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy--a simulation study based on experimental data. Neuroimage. 14: 936-45. PMID 11554812 DOI: 10.1006/nimg.2001.0879 |
0.509 |
|
| 2001 |
Bäckman L, Farde L. Dopamine and cognitive functioning: brain imaging findings in Huntington's disease and normal aging. Scandinavian Journal of Psychology. 42: 287-96. PMID 11501742 DOI: 10.1111/1467-9450.00238 |
0.315 |
|
| 2001 |
Halldin C, Gulyás B, Langer O, Farde L. Brain radioligands--state of the art and new trends. The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (Aimn) [and] the International Association of Radiopharmacology (Iar). 45: 139-52. PMID 11476163 |
0.71 |
|
| 2001 |
Talvik M, Nordström AL, Nyberg S, Olsson H, Halldin C, Farde L. No support for regional selectivity in clozapine-treated patients: a PET study with [(11)C]raclopride and [(11)C]FLB 457. The American Journal of Psychiatry. 158: 926-30. PMID 11384901 DOI: 10.1176/Appi.Ajp.158.6.926 |
0.532 |
|
| 2001 |
Sandell J, Halldin C, Pike VW, Chou YH, Varnäs K, Hall H, Marchais S, Nowicki B, Wikström HV, Swahn CG, Farde L. New halogenated [11C]WAY analogues, [11C]6FPWAY and [11C]6BPWAY--radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkey. Nuclear Medicine and Biology. 28: 177-85. PMID 11295428 DOI: 10.1016/S0969-8051(00)00181-5 |
0.498 |
|
| 2001 |
Nobuhara K, Farde L, Halldin C, Karlsson P, Swahn CG, Olsson H, Bergström KA, Larsson SA, Schnell PO, McPherson DW, Savonen A, Hiltunen J, Sedvall G. SPET imaging of central muscarinic acetylcholine receptors with iodine-123 labelled E-IQNP and Z-IQNP. European Journal of Nuclear Medicine. 28: 13-24. PMID 11202446 DOI: 10.1007/S002590000390 |
0.535 |
|
| 2001 |
Ito H, Sudo Y, Suhara T, Okubo Y, Halldin C, Farde L. Error analysis for quantification of [(11)C]FLB 457 binding to extrastriatal D(2) dopamine receptors in the human brain. Neuroimage. 13: 531-9. PMID 11170818 DOI: 10.1006/Nimg.2000.0717 |
0.49 |
|
| 2001 |
Kaasinen V, NÃ¥gren K, Hietala J, Farde L, Rinne JO. Sex differences in extrastriatal dopamine d(2)-like receptors in the human brain. The American Journal of Psychiatry. 158: 308-11. PMID 11156817 DOI: 10.1176/appi.ajp.158.2.308 |
0.512 |
|
| 2001 |
Cselényi Z, Olsson H, Gulyás B, Halldin C, Farde L. Detailed mapping of dopamine D2 receptors in the human limbic system using FLB 457 binding analysis in wavelet space Neuroimage. 13: 1299. DOI: 10.1016/S1053-8119(01)92613-8 |
0.699 |
|
| 2001 |
Savic I, Gulyas B, Lindström P, Halldin C, Farde L. Mesial temporal lobe epilepsy is associated with limbic reductions in serotonin 5HT1A receptor binding Neuroimage. 13: 833. DOI: 10.1016/S1053-8119(01)92175-5 |
0.363 |
|
| 2001 |
Gulyás B, Halldin C, Sóvágó J, Sandell J, Cselényi Z, Karlsson P, Kárpáti E, Kiss B, Vas A, Farde L. A novel principle of radiotracer administration in human brain mapping: pet studies on brain uptake and distribution of orally and intravenously administered [11C]vinpocetine Neuroimage. 13: 12. DOI: 10.1016/S1053-8119(01)91355-2 |
0.695 |
|
| 2001 |
Sandell J, Yu M, Emond P, Gulyas B, Cselenyi Z, Sovago J, Garreau L, Hall H, Chalon S, Guilloteau D, Någren K, Farde L, Halldin C. Radiolabeling, preliminary biological evaluation and pet examination in monkey of 5-methyl-6-nitroquipazine - a potential serotonin transporter radioligand Journal of Labelled Compounds and Radiopharmaceuticals. 44: S170-S172. DOI: 10.1002/JLCR.2580440159 |
0.357 |
|
| 2001 |
Sandell J, Mccarron JA, Halldin C, Pike VW, Gulyas B, Cselenyi Z, Sovago J, Marchais S, Wikström HV, Farde L. [18F]6FPWAY - a prospective 5-HT1A receptor radioligand - radiolabeling and pet examination in monkey - comparison with [11C]6FPWAY Journal of Labelled Compounds and Radiopharmaceuticals. 44: S167-S169. DOI: 10.1002/Jlcr.2580440158 |
0.45 |
|
| 2001 |
Någren K, Halldin C, Pike VW, Allonen T, Hietala J, Swahn C, Andrée B, Farde L, Osman S, Grasby P. Radioactive metabolites of the 5-HT1A receptor pet radioligand, [carbonyl-11C]way-100635, measured in human plasma samples Journal of Labelled Compounds and Radiopharmaceuticals. 44: S472-S474. DOI: 10.1002/JLCR.25804401167 |
0.404 |
|
| 2000 |
Farde L, Ginovart N, Halldin C, Chou YH, Olsson H, Swahn CG. A PET study of The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 3: 203-214. PMID 11343597 DOI: 10.1017/S1461145700002030 |
0.484 |
|
| 2000 |
Langer O, Halldin C, Chou Y, Sandell J, Swahn C, Någren K, Perrone R, Berardi F, Leopoldo M, Farde L. Carbon-11 pb-12: an attempt to visualize the dopamine d(4) receptor in the primate brain with positron emission tomography. Nuclear Medicine and Biology. 27: 707-14. PMID 11150701 DOI: 10.1016/S0969-8051(00)00154-2 |
0.535 |
|
| 2000 |
Hall H, Farde L, Halldin C, Lundkvist C, Sedvall G. Autoradiographic localization of 5-HT(2A) receptors in the human brain using [(3)H]M100907 and [(11)C]M100907. Synapse (New York, N.Y.). 38: 421-31. PMID 11044889 DOI: 10.1002/1098-2396(20001215)38:4<421::Aid-Syn7>3.0.Co;2-X |
0.567 |
|
| 2000 |
Chou YH, Halldin C, Farde L. Effect of amphetamine on extrastriatal D2 dopamine receptor binding in the primate brain: a PET study. Synapse (New York, N.Y.). 38: 138-43. PMID 11018787 DOI: 10.1002/1098-2396(200011)38:2<138::Aid-Syn4>3.0.Co;2-7 |
0.564 |
|
| 2000 |
Kaasinen V, Vilkman H, Hietala J, NÃ¥gren K, Helenius H, Olsson H, Farde L, Rinne J. Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain. Neurobiology of Aging. 21: 683-8. PMID 11016537 DOI: 10.1016/S0197-4580(00)00149-4 |
0.424 |
|
| 2000 |
Andrée B, Halldin C, Thorberg SO, Sandell J, Farde L. Use of PET and the radioligand [carbonyl-(11)C]WAY-100635 in psychotropic drug development. Nuclear Medicine and Biology. 27: 515-21. PMID 10962260 DOI: 10.1016/S0969-8051(00)00121-9 |
0.415 |
|
| 2000 |
Pike VW, Halldin C, Wikström H, Marchais S, McCarron JA, Sandell J, Nowicki B, Swahn CG, Osman S, Hume SP, Constantinou M, Andrée B, Farde L. Radioligands for the study of brain 5-HT(1A) receptors in vivo--development of some new analogues of way. Nuclear Medicine and Biology. 27: 449-55. PMID 10962249 DOI: 10.1016/S0969-8051(00)00110-4 |
0.468 |
|
| 2000 |
Talvik-Lotfi M, Nyberg S, Nordström AL, Ito H, Halldin C, Brunner F, Farde L. High 5HT2A receptor occupancy in M100907-treated schizophrenic patients. Psychopharmacology. 148: 400-3. PMID 10928313 DOI: 10.1007/S002130050069 |
0.346 |
|
| 2000 |
Nobuhara K, Halldin C, Hall H, Karlsson P, Farde L, Hiltunen J, McPherson DW, Savonen A, Bergström KA, Pauli S, Swahn CG, Larsson SA, Schnell PO, Sedvall G. Z-IQNP: a potential radioligand for SPECT imaging of muscarinic acetylcholine receptors in Alzheimer's disease. Psychopharmacology. 149: 45-55. PMID 10789882 DOI: 10.1007/S002139900356 |
0.584 |
|
| 2000 |
Bäckman L, Ginovart N, Dixon RA, Wahlin TB, Wahlin A, Halldin C, Farde L. Age-related cognitive deficits mediated by changes in the striatal dopamine system. The American Journal of Psychiatry. 157: 635-7. PMID 10739428 DOI: 10.1176/Ajp.157.4.635 |
0.353 |
|
| 2000 |
Farde L, Andrée B, Ginovart N, Halldin C, Thorberg S. PET-Determination of robalzotan (NAD-299) induced 5-HT(1A) receptor occupancy in the monkey brain. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 422-9. PMID 10700661 DOI: 10.1016/S0893-133X(99)00125-6 |
0.402 |
|
| 2000 |
Nyberg S, Farde L. Non-equipotent doses partly explain differences among antipsychotics - implications of PET studies. Psychopharmacology. 148: 22-3. PMID 10663413 DOI: 10.1007/S002130050020 |
0.314 |
|
| 2000 |
Langer O, Gulyás B, Sandell J, Laszlovszky I, Kiss B, Domány G, Ács T, Farde L, Halldin C. Radiochemical labelling of the dopamine D3 receptor ligand RGH-1756 Journal of Labelled Compounds and Radiopharmaceuticals. 43: 1069-1074. DOI: 10.1002/1099-1344(20001015)43:11<1069::Aid-Jlcr390>3.0.Co;2-N |
0.761 |
|
| 2000 |
Sandell J, Halldin C, Helfenbein J, Chou YH, Vercouillie J, Emond P, Swahn CG, Guilloteau D, Farde L. Synthesis of two dopamine D4 receptor ligands: 11C labelled chromeno[3,4-c]pyridin-5-ones Journal of Labelled Compounds and Radiopharmaceuticals. 43: 989-996. DOI: 10.1002/1099-1344(200009)43:10<989::AID-JLCR384>3.0.CO;2-3 |
0.371 |
|
| 2000 |
Sandell J, Halldin C, Helfenbein J, Chou Y, Vercouillie J, Emond P, Swahn C, Guilloteau D, Farde L. Synthesis of [11C]2?-carbomethoxy-3?-(3?-iodo-4?-methyl, -ethyl and isopropyl phenyl)nortropane as potential radiotracers for examination of the serotonin transporter with positron emission tomography Journal of Labelled Compounds and Radiopharmaceuticals. 43: 1033-1046. DOI: 10.1002/1099-1344(200009)43:10<1033::Aid-Jlcr389>3.0.Co;2-5 |
0.41 |
|
| 2000 |
Karlsson P, Farde L, Halldin C. Circadian rhythm in central D1-like dopamine receptors examined by PET Neuroimage. 11: S41. |
0.398 |
|
| 1999 |
Suhara T, Sudo Y, Okauchi T, Maeda J, Kawabe K, Suzuki K, Okubo Y, Nakashima Y, Ito H, Tanada S, Halldin C, Farde L. Extrastriatal dopamine D2 receptor density and affinity in the human brain measured by 3D PET. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 2: 73-82. PMID 11281973 DOI: 10.1017/S1461145799001431 |
0.537 |
|
| 1999 |
Okubo Y, Olsson H, Ito H, Lofti M, Suhara T, Halldin C, Farde L. PET mapping of extrastriatal D2-like dopamine receptors in the human brain using an anatomic standardization technique and [11C]FLB 457. Neuroimage. 10: 666-74. PMID 10600412 DOI: 10.1006/Nimg.1999.0502 |
0.557 |
|
| 1999 |
Bergström KA, Halldin C, Savonen A, Okubo Y, Hiltunen J, Nobuhara K, Swahn CG, Karlsson P, McPherson D, Knapp FF, Larsson S, Schnell PO, Farde L. Iodine-123 labelled Z-(R,R)-IQNP: a potential radioligand for visualization of M(1 )and M(2) muscarinic acetylcholine receptors in Alzheimer's disease. European Journal of Nuclear Medicine. 26: 1482-5. PMID 10552091 DOI: 10.1007/S002590050482 |
0.382 |
|
| 1999 |
Gulyás B, Halldin C, Karlsson P, Chou YH, Swahn CG, Bönöck P, Paróczai M, Farde L. Brain uptake and plasma metabolism of [11C]vinpocetine: a preliminary PET study in a cynomolgus monkey. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 9: 217-22. PMID 10540601 DOI: 10.1111/Jon199994217 |
0.705 |
|
| 1999 |
Olsson H, Halldin C, Swahn CG, Farde L. Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 19: 1164-73. PMID 10532641 DOI: 10.1097/00004647-199910000-00013 |
0.586 |
|
| 1999 |
Chou YH, Karlsson P, Halldin C, Olsson H, Farde L. A PET study of D(1)-like dopamine receptor ligand binding during altered endogenous dopamine levels in the primate brain. Psychopharmacology. 146: 220-7. PMID 10525759 DOI: 10.1007/S002130051110 |
0.52 |
|
| 1999 |
Langer O, Halldin C, Dollé F, Swahn CG, Olsson H, Karlsson P, Hall H, Sandell J, Lundkvist C, Vaufrey F, Loc'h C, Crouzel C, Mazière B, Farde L. Carbon-11 epidepride: a suitable radioligand for PET investigation of striatal and extrastriatal dopamine D2 receptors. Nuclear Medicine and Biology. 26: 509-18. PMID 10473189 DOI: 10.1016/S0969-8051(99)00005-0 |
0.556 |
|
| 1999 |
Lundkvist C, Loc'h C, Halldin C, Bottlaender M, Ottaviani M, Coulon C, Fuseau C, Mathis C, Farde L, Mazière B. Characterization of bromine-76-labelled 5-bromo-6-nitroquipazine for PET studies of the serotonin transporter. Nuclear Medicine and Biology. 26: 501-7. PMID 10473188 DOI: 10.1016/S0969-8051(99)00019-0 |
0.461 |
|
| 1999 |
Helfenbein J, Sandell J, Halldin C, Chalon S, Emond P, Okubo Y, Chou YH, Frangin Y, Douziech L, Gareau L, Swahn CG, Besnard JC, Farde L, Guilloteau D. PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter. Nuclear Medicine and Biology. 26: 491-9. PMID 10473187 DOI: 10.1016/S0969-8051(99)00004-9 |
0.447 |
|
| 1999 |
Gulyás B, Halldin C, Karlsson P, Chou YH, Swahn CG, Bönöczk P, Farde L. [Cerebral uptake and metabolism of (11C) Vinpocetine in monkeys: PET studies]. Orvosi Hetilap. 140: 1687-91. PMID 10461449 |
0.668 |
|
| 1999 |
Andrée B, Thorberg SO, Halldin C, Farde L. Pindolol binding to 5-HT1A receptors in the human brain confirmed with positron emission tomography. Psychopharmacology. 144: 303-5. PMID 10435400 DOI: 10.1007/S002130051009 |
0.507 |
|
| 1999 |
Jönsson EG, Nöthen MM, Grünhage F, Farde L, Nakashima Y, Propping P, Sedvall GC. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Molecular Psychiatry. 4: 290-6. PMID 10395223 DOI: 10.1038/Sj.Mp.4000532 |
0.619 |
|
| 1999 |
Lundkvist C, Halldin C, Swahn CG, Ginovart N, Farde L. Different brain radioactivity curves in a PET study with [11C]beta-CIT labelled in two different positions. Nuclear Medicine and Biology. 26: 343-50. PMID 10382835 DOI: 10.1016/S0969-8051(98)00111-5 |
0.328 |
|
| 1999 |
Nyberg S, Eriksson B, Oxenstierna G, Halldin C, Farde L. Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients. The American Journal of Psychiatry. 156: 869-75. PMID 10360125 DOI: 10.1176/Ajp.156.6.869 |
0.432 |
|
| 1999 |
Sandell J, Halldin C, Hall H, Thorberg SO, Werner T, Sohn D, Sedvall G, Farde L. Radiosynthesis and autoradiographic evaluation of [11C]NAD-299, a radioligand for visualization of the 5-HT1A receptor. Nuclear Medicine and Biology. 26: 159-64. PMID 10100214 DOI: 10.1016/S0969-8051(98)00091-2 |
0.642 |
|
| 1999 |
Ginovart N, Farde L, Halldin C, Swahn CG. Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with PET in nonhuman primates. Synapse (New York, N.Y.). 31: 154-62. PMID 10024013 DOI: 10.1002/(Sici)1098-2396(199902)31:2<154::Aid-Syn9>3.0.Co;2-K |
0.493 |
|
| 1999 |
Ito H, Halldin C, Farde L. Localization of 5-HT1A receptors in the living human brain using [carbonyl-11C]WAY-100635: PET with anatomic standardization technique. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 40: 102-9. PMID 9935065 |
0.392 |
|
| 1999 |
Ito H, Okubo Y, Halldin C, Farde L. Mapping of central D2 dopamine receptors in man using [11C]raclopride: PET with anatomic standardization technique. Neuroimage. 9: 235-42. PMID 9927552 DOI: 10.1006/Nimg.1998.0401 |
0.534 |
|
| 1999 |
Hall H, Halldin C, Guilloteau D, Chalon S, Emond P, Besnard J, Farde L, Sedvall G. Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [125I]PE2I. Neuroimage. 9: 108-16. PMID 9918732 DOI: 10.1006/Nimg.1998.0366 |
0.594 |
|
| 1998 |
Nyberg S, Dencker SJ, Malm U, Dahl ML, Svenson JO, Halldin C, Naskashima Y, Farde L. D(2)- and 5-HT(2) receptor occupancy in high-dose neuroleptic-treated patients. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 1: 95-101. PMID 11281952 DOI: 10.1017/S1461145798001229 |
0.439 |
|
| 1998 |
Halldin C, Foged C, Chou YH, Karlsson P, Swahn CG, Sandell J, Sedvall G, Farde L. Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 39: 2061-8. PMID 9867142 |
0.659 |
|
| 1998 |
Hall H, Halldin C, Farde L, Sedvall G. Whole hemisphere autoradiography of the postmortem human brain. Nuclear Medicine and Biology. 25: 715-9. PMID 9863555 DOI: 10.1016/S0969-8051(98)00053-5 |
0.624 |
|
| 1998 |
Farde L, Ito H, Swahn CG, Pike VW, Halldin C. Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 39: 1965-71. PMID 9829590 |
0.406 |
|
| 1998 |
Ito H, Hietala J, Blomqvist G, Halldin C, Farde L. Comparison of the transient equilibrium and continuous infusion method for quantitative PET analysis of [11C]raclopride binding. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 18: 941-50. PMID 9740097 DOI: 10.1097/00004647-199809000-00003 |
0.428 |
|
| 1998 |
Foged C, Halldin C, Swahn CG, Ginovart N, Karlsson P, Lundkvist C, Farde L. [11C]NNC 22-0215, a metabolically stable dopamine D1 radioligand for PET. Nuclear Medicine and Biology. 25: 503-8. PMID 9720669 DOI: 10.1016/S0969-8051(98)00010-9 |
0.561 |
|
| 1998 |
Nyberg S, Nilsson U, Okubo Y, Halldin C, Farde L. Implications of brain imaging for the management of schizophrenia. International Clinical Psychopharmacology. 13: S15-20. PMID 9690965 DOI: 10.1097/00004850-199803003-00003 |
0.482 |
|
| 1998 |
Andrée B, Nyberg S, Ito H, Ginovart N, Brunner F, Jaquet F, Halldin C, Farde L. Positron emission tomographic analysis of dose-dependent MDL 100,907 binding to 5-hydroxytryptamine-2A receptors in the human brain. Journal of Clinical Psychopharmacology. 18: 317-23. PMID 9690698 DOI: 10.1097/00004714-199808000-00012 |
0.489 |
|
| 1998 |
Nordström AL, Farde L. Plasma prolactin and central D2 receptor occupancy in antipsychotic drug-treated patients. Journal of Clinical Psychopharmacology. 18: 305-10. PMID 9690696 DOI: 10.1097/00004714-199808000-00010 |
0.404 |
|
| 1998 |
Emond P, Farde L, Chalon S, Belzung C, Mauclaire V, Chiron JP, Halldin C, Besnard JC, Guilloteau D. Toxicity, mutagenicity, and behavioral effects of beta-CIT, a ligand for dopamine transporter exploration by SPECT. Nuclear Medicine and Biology. 25: 405-9. PMID 9639303 DOI: 10.1016/S0969-8051(97)00227-8 |
0.319 |
|
| 1998 |
Osman S, Lundkvist C, Pike VW, Halldin C, McCarron JA, Swahn CG, Farde L, Ginovart N, Luthra SK, Gunn RN, Bench CJ, Sargent PA, Grasby PM. Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modelling. Nuclear Medicine and Biology. 25: 215-23. PMID 9620626 DOI: 10.1016/S0969-8051(97)00206-0 |
0.487 |
|
| 1998 |
Bergström KA, Halldin C, Hiltunen J, Swahn CG, Ito H, Ginovart N, Hall H, McPherson DW, Knapp FF, Larsson S, Schnell PO, Farde L. Evaluation and metabolite studies of 125I- and 123I-labelled E-(R,R)-IQNP: potential radioligands for visualization of M1 muscarinic acetylcholine receptors in brain. Nuclear Medicine and Biology. 25: 209-14. PMID 9620625 DOI: 10.1016/S0969-8051(97)00198-4 |
0.395 |
|
| 1998 |
Kuikka JT, Baulieu JL, Hiltunen J, Halldin C, Bergström KA, Farde L, Emond P, Chalon S, Yu M, Nikula T, Laitinen T, Karhu J, Tupala E, Hallikainen T, Kolehmainen V, et al. Pharmacokinetics and dosimetry of iodine-123 labelled PE2I in humans, a radioligand for dopamine transporter imaging. European Journal of Nuclear Medicine. 25: 531-4. PMID 9575250 DOI: 10.1007/S002590050254 |
0.417 |
|
| 1998 |
Pike VW, Halldin C, McCarron JA, Lundkvist C, Hirani E, Olsson H, Hume SP, Karlsson P, Osman S, Swahn CG, Hall H, Wikström H, Mensonidas M, Poole KG, Farde L. [carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo. European Journal of Nuclear Medicine. 25: 338-46. PMID 9553162 DOI: 10.1007/S002590050230 |
0.519 |
|
| 1998 |
Nordström AL, Nyberg S, Olsson H, Farde L. Positron emission tomography finding of a high striatal D2 receptor occupancy in olanzapine-treated patients. Archives of General Psychiatry. 55: 283-4. PMID 9510228 DOI: 10.1001/Archpsyc.55.3.283 |
0.465 |
|
| 1998 |
Ito H, Nyberg S, Halldin C, Lundkvist C, Farde L. PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 39: 208-14. PMID 9443763 |
0.461 |
|
| 1998 |
Hiltunen J, Akerman KK, Kuikka JT, Bergström KA, Halldin C, Nikula T, Räsänen P, Tiihonen J, Vauhkonen M, Karhu J, Kupila J, Länsimies E, Farde L. Iodine-123 labeled nor-beta-CIT as a potential tracer for serotonin transporter imaging in the human brain with single-photon emission tomography. European Journal of Nuclear Medicine. 25: 19-23. PMID 9396870 DOI: 10.1007/S002590050189 |
0.34 |
|
| 1998 |
Hall H, Halldin C, Farde L, Sedvall G. Distribution of Serotonin Receptor Subtypes in the Post-Mortem Human Brain Neuroimage. 7: S291. DOI: 10.1016/S1053-8119(18)31124-8 |
0.533 |
|
| 1998 |
Farde L, Andrée B, Ginovart N, Halldin C, Thorberg S. PET determination of robalzotan occupancy of 5-HT1A receptors in the monkey brain European Neuropsychopharmacology. 8: S168. DOI: 10.1016/S0924-977X(98)80214-9 |
0.487 |
|
| 1998 |
Farde L, Olsson H, Talvik-Lotfi M, Halldin C. Striatai and extrastriatal D2-dopamine receptor occupancy during haloperidol and ciozapine treatment European Neuropsychopharmacology. 8: S83. DOI: 10.1016/S0924-977X(98)80050-3 |
0.442 |
|
| 1997 |
Farde L. Brain imaging of schizophrenia--the dopamine hypothesis. Schizophrenia Research. 28: 157-62. PMID 9468350 DOI: 10.1016/S0920-9964(97)00121-7 |
0.429 |
|
| 1997 |
Farde L, Suhara T, Nyberg S, Karlsson P, Nakashima Y, Hietala J, Halldin C. A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients. Psychopharmacology. 133: 396-404. PMID 9372541 DOI: 10.1007/S002130050420 |
0.564 |
|
| 1997 |
Günther I, Hall H, Halldin C, Swahn CG, Farde L, Sedvall G. [125I] beta-CIT-FE and [125I] beta-CIT-FP are superior to [125I] beta-CIT for dopamine transporter visualization: autoradiographic evaluation in the human brain. Nuclear Medicine and Biology. 24: 629-34. PMID 9352533 DOI: 10.1016/S0969-8051(97)00081-4 |
0.503 |
|
| 1997 |
Lundkvist C, Halldin C, Ginovart N, Swahn CG, Farde L. [18F] beta-CIT-FP is superior to [11C] beta-CIT-FP for quantitation of the dopamine transporter. Nuclear Medicine and Biology. 24: 621-7. PMID 9352532 DOI: 10.1016/S0969-8051(97)00077-2 |
0.359 |
|
| 1997 |
Farde L, Ginovart N, Ito H, Lundkvist C, Pike VW, McCarron JA, Halldin C. PET-characterization of [carbonyl-11C]WAY-100635 binding to 5-HT1A receptors in the primate brain. Psychopharmacology. 133: 196-202. PMID 9342787 DOI: 10.1007/S002130050391 |
0.56 |
|
| 1997 |
Nyberg S, Farde L, Halldin C. Delayed normalization of central D2 dopamine receptor availability after discontinuation of haloperidol decanoate. Preliminary findings. Archives of General Psychiatry. 54: 953-8. PMID 9337776 DOI: 10.1001/Archpsyc.1997.01830220079011 |
0.496 |
|
| 1997 |
Foged C, Halldin C, Loc'h C, Mazière B, Pauli S, Maziére M, Hansen HC, Suhara T, Swahn CG, Karlsson P, Farde L. Bromine-76 and carbon-11 labelled NNC 13-8199, metabolically stable benzodiazepine receptor agonists as radioligands for positron emission tomography. European Journal of Nuclear Medicine. 24: 1261-7. PMID 9323267 DOI: 10.1007/S002590050150 |
0.496 |
|
| 1997 |
Hall H, Halldin C, Jerning E, Osterlund M, Farde L, Sedvall G. Autoradiographic comparison of [125I]epidepride and [125I]NCQ 298 binding to human brain extrastriated dopamine receptors. Nuclear Medicine and Biology. 24: 389-93. PMID 9290072 DOI: 10.1016/S0969-8051(97)80004-2 |
0.669 |
|
| 1997 |
Andrée B, Halldin C, Vrijmoed-de Vries M, Farde L. Central 5-HT2A and D2 dopamine receptor occupancy after sublingual administration of ORG 5222 in healthy men. Psychopharmacology. 131: 339-45. PMID 9226735 DOI: 10.1007/S002130050301 |
0.55 |
|
| 1997 |
Farde L, Mack RJ, Nyberg S, Halldin C. D2 occupancy, extrapyramidal side effects and antipsychotic drug treatment: a pilot study with sertindole in healthy subjects. International Clinical Psychopharmacology. 12: S3-7. PMID 9179638 DOI: 10.1097/00004850-199702001-00002 |
0.475 |
|
| 1997 |
Bergström KA, Halldin C, Hall H, Lundkvist C, Ginovart N, Swahn CG, Farde L. In vitro and in vivo characterisation of nor-beta-CIT: a potential radioligand for visualisation of the serotonin transporter in the brain. European Journal of Nuclear Medicine. 24: 596-601. PMID 9169564 DOI: 10.1007/Bf00841395 |
0.371 |
|
| 1997 |
Ginovart N, Lundin A, Farde L, Halldin C, Bäckman L, Swahn CG, Pauli S, Sedvall G. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease. Brain : a Journal of Neurology. 120: 503-14. PMID 9126061 DOI: 10.1093/Brain/120.3.503 |
0.605 |
|
| 1997 |
Ginovart N, Farde L, Halldin C, Swahn CG. Effect of reserpine-induced depletion of synaptic dopamine on [11C]raclopride binding to D2-dopamine receptors in the monkey brain. Synapse (New York, N.Y.). 25: 321-5. PMID 9097390 DOI: 10.1002/(Sici)1098-2396(199704)25:4<321::Aid-Syn2>3.0.Co;2-C |
0.539 |
|
| 1997 |
Volkow ND, Rosen B, Farde L. Imaging the living human brain: magnetic resonance imaging and positron emission tomography. Proceedings of the National Academy of Sciences of the United States of America. 94: 2787-8. PMID 9096295 DOI: 10.1073/pnas.94.7.2787 |
0.332 |
|
| 1997 |
Hall H, Lundkvist C, Halldin C, Farde L, Pike VW, McCarron JA, Fletcher A, Cliffe IA, Barf T, Wikström H, Sedvall G. Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635. Brain Research. 745: 96-108. PMID 9037397 DOI: 10.1016/S0006-8993(96)01131-6 |
0.64 |
|
| 1997 |
Farde L, Gustavsson JP, Jönsson E. D2 dopamine receptors and personality traits. Nature. 385: 590. PMID 9024656 DOI: 10.1038/385590a0 |
0.428 |
|
| 1997 |
Nyberg S, Farde L, Halldin C. A PET study of 5-HT2 and D2 dopamine receptor occupancy induced by olanzapine in healthy subjects. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 16: 1-7. PMID 8981383 DOI: 10.1016/S0893-133X(96)00218-7 |
0.439 |
|
| 1997 |
Farde L. S.26.03 A PET-study of extrastriatal D2-dopamine receptors European Neuropsychopharmacology. 7: S129-S130. DOI: 10.1016/S0924-977X(97)88443-X |
0.41 |
|
| 1997 |
Karlsson P, Farde L, Halldin C, Sedvall G. D1-Dopamine receptors in schizophrenia examined by pet Schizophrenia Research. 24: 178-179. DOI: 10.1016/S0920-9964(97)82513-3 |
0.626 |
|
| 1997 |
Bymaster FP, Whitesitt CA, Shannon HE, DeLapp N, Ward JS, Calligaro DO, Shipley LA, Buelke-Sam JL, Bodick NC, Farde L, Sheardown MJ, Olesen PH, Hansen KT, Suzdak PD, Swedberg MD, et al. Xanomeline: A selective muscarinic agonist for the treatment of Alzheimer's disease Drug Development Research. 40: 158-170. DOI: 10.1002/(SICI)1098-2299(199702)40:2<158::AID-DDR6>3.0.CO;2-K |
0.376 |
|
| 1996 |
Hall H, Halldin C, Dijkstra D, Wikström H, Wise LD, Pugsley TA, Sokoloff P, Pauli S, Farde L, Sedvall G. Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907. Psychopharmacology. 128: 240-7. PMID 8972543 DOI: 10.1007/S002130050131 |
0.606 |
|
| 1996 |
Foged C, Halldin C, Loc'h C, Mazière B, Karlsson P, Mazière M, Swahn CG, Farde L. 11C- and 76Br-labelled NNC 22-0010, selective dopamine D1 receptor radioligands for PET. Nuclear Medicine and Biology. 23: 837-44. PMID 8940728 DOI: 10.1016/0969-8051(96)00083-2 |
0.537 |
|
| 1996 |
Loc'h C, Halldin C, Bottlaender M, Swahn CG, Moresco RM, Mazière M, Farde L, Mazière B. Preparation of [76Br]FLB 457 and [76Br]FLB 463 for examination of striatal and extrastriatal dopamine D-2 receptors with PET. Nuclear Medicine and Biology. 23: 813-9. PMID 8940725 DOI: 10.1016/0969-8051(96)00078-9 |
0.522 |
|
| 1996 |
Nyberg S, Farde L, Halldin C. Test-retest reliability of central [11C]raclopride binding at high D2 receptor occupancy. A PET study in haloperidol-treated patients. Psychiatry Research. 67: 163-71. PMID 8912956 DOI: 10.1016/0925-4927(96)02921-6 |
0.534 |
|
| 1996 |
Osman S, Lundkvist C, Pike VW, Halldin C, McCarron JA, Swahn CG, Ginovart N, Luthra SK, Bench CJ, Grasby PM, Wikström H, Barf T, Cliffe IA, Fletcher A, Farde L. Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methyl-11C]WAY-100635, in monkey and human plasma by HPLC: comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET. Nuclear Medicine and Biology. 23: 627-34. PMID 8905828 DOI: 10.1016/0969-8051(96)00061-3 |
0.467 |
|
| 1996 |
Halldin C, Farde L, Lundkvist C, Ginovart N, Nakashima Y, Karlsson P, Swahn CG. [11C]beta-CIT-FE, a radioligand for quantitation of the dopamine transporter in the living brain using positron emission tomography. Synapse (New York, N.Y.). 22: 386-90. PMID 8867033 DOI: 10.1002/(Sici)1098-2396(199604)22:4<386::Aid-Syn10>3.0.Co;2-W |
0.401 |
|
| 1996 |
Farde L, Suhara T, Halldin C, Nybäck H, Nakashima Y, Swahn CG, Karlsson P, Ginovart N, Bymaster FP, Shannon HE, Foged C, Suzdak PD, Sauerberg P. PET study of the M1-agonists [11C]xanomeline and [11C]butylthio-TZTP in monkey and man. Dementia (Basel, Switzerland). 7: 187-95. PMID 8835881 DOI: 10.1159/000106877 |
0.511 |
|
| 1996 |
Suhara T, Farde L, Halldin C, NÃ¥gren K, Karlsson P. Effects of cocaine on [11C]norepinephrine and [11C] beta-CIT uptake in the primate peripheral organs measured by PET. Annals of Nuclear Medicine. 10: 85-8. PMID 8814732 DOI: 10.1007/Bf03165058 |
0.317 |
|
| 1996 |
NÃ¥gren K, Halldin C, Swahn CG, Suhara T, Farde L. [11C]metaraminol, a false neurotransmitter: preparation, metabolite studies and positron emission tomography examination in monkey. Nuclear Medicine and Biology. 23: 221-7. PMID 8782229 DOI: 10.1016/0969-8051(95)02050-0 |
0.397 |
|
| 1996 |
Foged C, Halldin C, Hiltunen J, Braestrup C, Thomsen C, Hansen HC, Suhara T, Pauli S, Swahn CG, Karlsson P, Larsson S, Farde L. Development of 123I-labelled NNC 13-8241 as a radioligand for SPECT visualization of benzodiazepine receptor binding. Nuclear Medicine and Biology. 23: 201-9. PMID 8782227 DOI: 10.1016/0969-8051(95)02041-1 |
0.467 |
|
| 1996 |
Farde L. The advantage of using positron emission tomography in drug research. Trends in Neurosciences. 19: 211-4. PMID 8761953 DOI: 10.1016/0166-2236(96)40002-9 |
0.373 |
|
| 1996 |
Nyberg S, Nakashima Y, Nordström AL, Halldin C, Farde L. Positron emission tomography of in-vivo binding characteristics of atypical antipsychotic drugs. Review of D2 and 5-HT2 receptor occupancy studies and clinical response. The British Journal of Psychiatry. Supplement. 40-4. PMID 8733822 DOI: 10.1192/S0007125000298309 |
0.44 |
|
| 1996 |
Hall H, Farde L, Halldin C, Hurd YL, Pauli S, Sedvall G. Autoradiographic localization of extrastriatal D2-dopamine receptors in the human brain using [125I]epidepride. Synapse (New York, N.Y.). 23: 115-23. PMID 8723716 DOI: 10.1002/(Sici)1098-2396(199606)23:2<115::Aid-Syn7>3.0.Co;2-C |
0.645 |
|
| 1996 |
Kuikka JT, Hiltunen J, Foged C, Bergström KA, Halldin C, Akerman K, Tiihonen J, Farde L. Initial human studies with single-photon emission tomography using iodine-123 labelled 3-(5-cyclopropyl-1,2,4-oxadiazo-3-yl)- 7-iodo-5, 6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]-benzodiazepine (NNC 13-8241). European Journal of Nuclear Medicine. 23: 798-803. PMID 8662119 DOI: 10.1007/Bf00843709 |
0.438 |
|
| 1996 |
Lundkvist C, Halldin C, Ginovart N, Nyberg S, Swahn CG, Carr AA, Brunner F, Farde L. [11C]MDL 100907, a radioligland for selective imaging of 5-HT(2A) receptors with positron emission tomography. Life Sciences. 58: PL 187-92. PMID 8602111 DOI: 10.1016/0024-3205(96)00013-6 |
0.527 |
|
| 1996 |
Sedvall G, Farde L. Dopamine receptors in schizophrenia. Lancet. 347: 264. PMID 8551909 DOI: 10.1016/S0140-6736(96)90440-7 |
0.566 |
|
| 1996 |
NORDSTRÖM A, FARDE L, NYBERG S, KARLSSON P, HALLDIN C, SEDVALL G. Dr. Nordström and Colleagues Reply American Journal of Psychiatry. 153: 1240-1240. DOI: 10.1176/Ajp.153.9.1240 |
0.431 |
|
| 1996 |
Karlsson P, Farde L, Halldin C, Sedvall G. Reduced D1-dopamine receptor binding in schizophrenia — Relation to psychopathology European Neuropsychopharmacology. 6: 212-213. DOI: 10.1016/0924-977X(96)88301-5 |
0.606 |
|
| 1996 |
Hall H, Lundkvist C, Halldin C, Pike V, McCarron J, Fletcher A, Cliffe I, Farde L, Sedvall G. Autoradiographic localization of 5-HT1A-receptors in the human brain European Neuropsychopharmacology. 6: 212. DOI: 10.1016/0924-977X(96)88297-6 |
0.582 |
|
| 1996 |
Farde L, Ginovart N, Halldin C. Pet-studies on the dopamine system in vivo European Neuropsychopharmacology. 6: 165. DOI: 10.1016/0924-977X(96)88068-0 |
0.324 |
|
| 1996 |
Hall H, Hurd Y, Suzuki M, Farde L, Halldin C, Sedvall G. Distribution of dopamine receptor subtypes in the post-mortem human brain European Neuropsychopharmacology. 6: 157. DOI: 10.1016/0924-977X(96)88033-3 |
0.618 |
|
| 1996 |
Ginovart N, Lundin A, Farde L, Halldin C, Swahn C, Pauli S, Sedvall G. In vivo examination of the Pre- and postsynaptic dopamine neurons in huntington's disease European Neuropsychopharmacology. 6: 130. DOI: 10.1016/0924-977X(96)87905-3 |
0.504 |
|
| 1996 |
Farde L, Ginovart N, Halldin C. PET studies on the dopamine system in vivo European Neuropsychopharmacology. 6: S4-8. DOI: 10.1016/0924-977X(96)83164-6 |
0.436 |
|
| 1996 |
Karlsson P, Farde L, Halldin C, Sedvall G. PET D1-receptor studies in schizophrenia European Psychiatry. 11: 231s-232s. DOI: 10.1016/0924-9338(96)88691-3 |
0.545 |
|
| 1996 |
Nordström A, Nyberg S, Farde L. Dopamine and serotonin receptor occupancy in patients treated with antipsychotics European Psychiatry. 11: 202s. DOI: 10.1016/0924-9338(96)88581-6 |
0.318 |
|
| 1996 |
Nordström A, Farde L. Dopamine receptors and neurological side effects European Psychiatry. 11: 183s. DOI: 10.1016/0924-9338(96)88511-7 |
0.319 |
|
| 1996 |
Nyberg S, Farde L, Halldin C. Long-time persistence of D2 dopamine receptor occupancy after discontinuation of haloperidol decanoate Schizophrenia Research. 18: 199-200. DOI: 10.1016/0920-9964(96)85622-2 |
0.324 |
|
| 1996 |
Karlsson P, Farde L, Halldin C, Sedvall G. Decrease of D1-dopamine receptor binding in the frontal cortex of neuroleptic naive schizophrenic patients measured by PET Schizophrenia Research. 18: 198. DOI: 10.1016/0920-9964(96)85618-0 |
0.604 |
|
| 1996 |
Müller L, Halldin C, Lundkvist C, Swahn C-, Foged C, Hall H, Karlsson P, Ginovart N, Nakashima Y, Suhara T, Farde L. Development of radioligands for the dopamine transporter Journal of Radioanalytical and Nuclear Chemistry Articles. 206: 133-144. DOI: 10.1007/Bf02040050 |
0.371 |
|
| 1995 |
Farde L, Halldin C, NÃ¥gren K, Karlsson P, Swahn CG, Suhara T. PET examination of the monkey heart with high specific radioactivity [11C]norepinephrine and [11C]metaraminol. Nuclear Medicine and Biology. 22: 1053-6. PMID 8998466 DOI: 10.1016/0969-8051(95)02030-6 |
0.388 |
|
| 1995 |
Swahn CG, Halldin C, NÃ¥gren K, Farde L. An HPLC-method for determination of ligand metabolism during PET studies with [11C]metaraminol and [11C]norepinephrine. Nuclear Medicine and Biology. 22: 1045-8. PMID 8998464 DOI: 10.1016/0969-8051(95)02028-4 |
0.385 |
|
| 1995 |
Nyberg S, Nordström AL, Halldin C, Farde L. Positron emission tomography studies on D2 dopamine receptor occupancy and plasma antipsychotic drug levels in man. International Clinical Psychopharmacology. 10: 81-5. PMID 8866769 |
0.369 |
|
| 1995 |
Sedvall G, Pauli S, Karlsson P, Farde L, Nordström AL, Nyberg S, Halldin C. PET imaging of neuroreceptors in schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 5: 25-30. PMID 8775755 DOI: 10.1016/0924-977X(95)00021-G |
0.684 |
|
| 1995 |
Nyberg S, Farde L, Bartfai A, Halldin C. Central D2 receptor occupancy and effects of zuclopenthixol acetate in humans. International Clinical Psychopharmacology. 10: 221-7. PMID 8748043 DOI: 10.1097/00004850-199511000-00003 |
0.43 |
|
| 1995 |
Karlsson P, Smith L, Farde L, Härnryd C, Sedvall G, Wiesel FA. Lack of apparent antipsychotic effect of the D1-dopamine receptor antagonist SCH39166 in acutely ill schizophrenic patients. Psychopharmacology. 121: 309-16. PMID 8584611 DOI: 10.1007/BF02246068 |
0.534 |
|
| 1995 |
Karlsson P, Sedvall G, Halldin C, Swahn CG, Farde L. Evaluation of SCH 39166 as PET ligand for central D1 dopamine receptor binding and occupancy in man. Psychopharmacology. 121: 300-8. PMID 8584610 DOI: 10.1007/Bf02246067 |
0.683 |
|
| 1995 |
Lundkvist C, Halldin C, Swahn CG, Hall H, Karlsson P, Nakashima Y, Wang S, Milius RA, Neumeyer JL, Farde L. [O-methyl-11C]beta-CIT-FP, a potential radioligand for quantitation of the dopamine transporter: preparation, autoradiography, metabolite studies, and positron emission tomography examinations. Nuclear Medicine and Biology. 22: 905-13. PMID 8547888 DOI: 10.1016/0969-8051(95)00029-W |
0.401 |
|
| 1995 |
Müller L, Hall H, Halldin C, Farde L, Hohlweg R, Suzdak PD, Nielsen EB, Foged C. Synthesis and binding properties of [3H]NNC 12-0781, a new radioligand for the dopamine reuptake system. Nuclear Medicine and Biology. 22: 711-7. PMID 8535331 DOI: 10.1016/0969-8051(95)00011-L |
0.383 |
|
| 1995 |
Nyberg S, Farde L, Halldin C, Dahl ML, Bertilsson L. D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate. The American Journal of Psychiatry. 152: 173-8. PMID 7840348 |
0.34 |
|
| 1995 |
Bergström KA, Halldin C, Kuikka JT, Swahn CG, Tiihonen J, Hiltunen J, Länsimies E, Farde L. Lipophilic metabolite of [123I]beta-CIT in human plasma may obstruct quantitation of the dopamine transporter. Synapse (New York, N.Y.). 19: 297-300. PMID 7792723 DOI: 10.1002/Syn.890190407 |
0.387 |
|
| 1995 |
Halldin C, Farde L, Högberg T, Mohell N, Hall H, Suhara T, Karlsson P, Nakashima Y, Swahn CG. Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 36: 1275-81. PMID 7790956 |
0.473 |
|
| 1995 |
Karlsson P, Farde L, Halldin C, Sedvall G, Ynddal L, Sloth-Nielsen M. Oral administration of NNC 756--a placebo controlled PET study of D1-dopamine receptor occupancy and pharmacodynamics in man. Psychopharmacology. 119: 1-8. PMID 7675940 DOI: 10.1007/Bf02246046 |
0.633 |
|
| 1995 |
Sedvall G, Farde L. Chemical brain anatomy in schizophrenia. Lancet. 346: 743-9. PMID 7658878 DOI: 10.1016/S0140-6736(95)91508-7 |
0.439 |
|
| 1995 |
Sedvall G, Pauli S, Farde L, Karlsson P, Nyberg S, Nordström AL. Recent developments in PET scan imaging of neuroreceptors in schizophrenia. The Israel Journal of Psychiatry and Related Sciences. 32: 22-9. PMID 7622344 |
0.631 |
|
| 1995 |
Sedvall G, Farde L, Hall H, Halldin C, Karlsson P, Nordström AL, Nyberg S, Pauli S. Utilization of radioligands in schizophrenia research. Clinical Neuroscience (New York, N.Y.). 3: 112-21. PMID 7583617 |
0.612 |
|
| 1995 |
Nordström AL, Farde L, Nyberg S, Karlsson P, Halldin C, Sedvall G. D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients. The American Journal of Psychiatry. 152: 1444-9. PMID 7573582 DOI: 10.1176/Ajp.152.10.1444 |
0.619 |
|
| 1995 |
Farde L, Hall H, Pauli S, Halldin C. Variability in D2-dopamine receptor density and affinity: a PET study with [11C]raclopride in man. Synapse (New York, N.Y.). 20: 200-8. PMID 7570351 DOI: 10.1002/Syn.890200303 |
0.541 |
|
| 1995 |
Hall H, Halldin C, Nyberg S, Farde L, Sedvall G. Effect of clozapine and risperidone on 5-HT2 and D2-dopamine receptor binding in the post-mortem human brain. An autoradiographic study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 5: 19-25. PMID 7542051 DOI: 10.1016/0924-977X(94)00127-W |
0.663 |
|
| 1995 |
Farde L, Nyberg S, Oxenstierna G, Nakashima Y, Halldin C, Ericsson B. Positron emission tomography studies on D2 and 5-HT2 receptor binding in risperidone-treated schizophrenic patients. Journal of Clinical Psychopharmacology. 15: 19S-23S. PMID 7537284 DOI: 10.1097/00004714-199502001-00004 |
0.43 |
|
| 1995 |
Nordström AL, Farde L, Eriksson L, Halldin C. No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone. Psychiatry Research. 61: 67-83. PMID 7480390 DOI: 10.1016/0925-4927(95)02732-D |
0.553 |
|
| 1995 |
Farde L, Nordström A, Karlsson P, Halldin C, Sedvall G. Positron Emission Tomography Studies on Dopamine Receptors in Schizophrenia Clinical Neuropharmacology. 18: S121-S129. DOI: 10.1097/00002826-199501001-00014 |
0.603 |
|
| 1995 |
HALL H, FARDE L, HALLDIN C, NYBERG S, MOHELL N, JACKSON D, SEDVALL G. Extra-striatal dopamine receptors studied with [125I]epideprideIn VITRO and [[11C]FLB 457in vivo Pharmacological Research. 31: 29-29. DOI: 10.1016/1043-6618(95)86377-X |
0.573 |
|
| 1995 |
Hall H, Halldin C, Suzuki M, Dijkstra D, Wikström H, Wise L, Pugsley T, Hurd Y, Farde L, Pauli S, Sedvall G. P-4-61 Autoradiographic comparison of D2- and D3-dopamine receptor localization in the post mortem human brain using [125I]epidepride and [3H]PD 128907 European Neuropsychopharmacology. 5: 346. DOI: 10.1016/0924-977X(95)90581-W |
0.597 |
|
| 1995 |
Karlsson P, Farde L, Halldin C, Sedvall G. Decreased D1-dopamine receptor binding in drug naive schizophrenic patients examined by pet Schizophrenia Research. 15: 86. DOI: 10.1016/0920-9964(95)95267-D |
0.658 |
|
| 1995 |
Loc'h C, Müller L, Ottaviani M, Halldin C, Farde L, Mazière B. Synthesis of 2β-carbomethoxy-3β-(4-[76Br]bromophenyl)tropane ([76Br]β-CBT), a pet tracer for in vivo imaging of the dopamine uptake sites Journal of Labelled Compounds and Radiopharmaceuticals. 36: 385-392. DOI: 10.1002/Jlcr.2580360412 |
0.305 |
|
| 1994 |
Halldin C, Högberg T, Farde L. Fluorine-18-labelled NCQ 115, a selective dopamine D-2 receptor ligand. Preparation and positron emission tomography. Nuclear Medicine and Biology. 21: 627-31. PMID 9234320 DOI: 10.1016/0969-8051(94)90028-0 |
0.464 |
|
| 1994 |
Farde L, Halldin C, Müller L, Suhara T, Karlsson P, Hall H. PET study of [11C]beta-CIT binding to monoamine transporters in the monkey and human brain. Synapse (New York, N.Y.). 16: 93-103. PMID 8197578 DOI: 10.1002/Syn.890160203 |
0.445 |
|
| 1994 |
NÃ¥gren K, Schoeps KO, Halldin C, Swahn CG, Farde L. Selective synthesis of racemic 1-11C-labelled norepinephrine, octopamine, norphenylephrine and phenylethanolamine using [11C]nitromethane. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 45: 515-21. PMID 8186772 DOI: 10.1016/0969-8043(94)90117-1 |
0.315 |
|
| 1994 |
Sedvall G, Karlsson P, Lundin A, Anvret M, Suhara T, Halldin C, Farde L. Dopamine D1 receptor number--a sensitive PET marker for early brain degeneration in Huntington's disease. European Archives of Psychiatry and Clinical Neuroscience. 243: 249-55. PMID 8172940 DOI: 10.1007/Bf02191583 |
0.678 |
|
| 1994 |
Müller L, Halldin C, Foged C, Karlsson P, Hall H, Swahn CG, Suzdak PD, Hohlweg R, Nielsen EB, Farde L. Preparation of a potential positron emission tomographic radioligand for the dopamine transporter. European Journal of Nuclear Medicine. 21: 131-7. PMID 8162936 DOI: 10.1007/Bf00175760 |
0.482 |
|
| 1994 |
Farde L, Pauli S, Litton JE, Halldin C, Neiman J, Sedvall G. PET-determination of benzodiazepine receptor binding in studies on alcoholism. Exs. 71: 143-53. PMID 8032146 |
0.555 |
|
| 1994 |
Farde L, Halldin C, NÃ¥gren K, Suhara T, Karlsson P, Schoeps KO, Swahn CG, Bone D. Positron emission tomography shows high specific uptake of racemic carbon-11 labelled norepinephrine in the primate heart. European Journal of Nuclear Medicine. 21: 345-7. PMID 8005159 DOI: 10.1007/Bf00947971 |
0.353 |
|
| 1994 |
Farde L, Nordström AL, Nyberg S, Halldin C, Sedvall G. D1-, D2-, and 5-HT2-receptor occupancy in clozapine-treated patients. The Journal of Clinical Psychiatry. 55: 67-9. PMID 7961577 |
0.571 |
|
| 1994 |
Wiesel FA, Nordström AL, Farde L, Eriksson B. An open clinical and biochemical study of ritanserin in acute patients with schizophrenia. Psychopharmacology. 114: 31-8. PMID 7846205 DOI: 10.1007/Bf02245441 |
0.437 |
|
| 1994 |
Movin-Osswald G, Karlsson P, Hammarlund-Udenaes M, Farde L. Influence of rate of administration of raclopride on akathisia and prolactin response. Psychopharmacology. 114: 248-56. PMID 7838916 DOI: 10.1007/Bf02244845 |
0.311 |
|
| 1994 |
Hall H, Sedvall G, Magnusson O, Kopp J, Halldin C, Farde L. Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 11: 245-56. PMID 7531978 DOI: 10.1038/Sj.Npp.1380111 |
0.659 |
|
| 1994 |
Farde L, Nordström A, Nyberg S, Halldin C. D2 and 5-HT2 receptor occupancy in antipsychotic drug treated patients European Neuropsychopharmacology. 4: 221-223. DOI: 10.1016/0924-977X(94)90051-5 |
0.463 |
|
| 1994 |
Farde L, Suhara T, Halldin C, Karlsson P, Nybäck H, Müller L, Fuged C, Sauerberg P, Lucas R. New radioligands for pet-examination of central muscarinic receptors Neurobiology of Aging. 15: S105. DOI: 10.1016/0197-4580(94)92885-1 |
0.512 |
|
| 1994 |
Swahn C, Halldin C, Farde L, Sedvall G. Metabolism of the PET ligand [11C]SCH 23390. Identification of two radiolabelled metabolites with HPLC Human Psychopharmacology: Clinical and Experimental. 9: 25-31. DOI: 10.1002/Hup.470090103 |
0.582 |
|
| 1993 |
Müller L, Halldin C, Farde L, Karlsson P, Hall H, Swahn CG, Neumeyer J, Gao Y, Milius R. [11C] beta-CIT, a cocaine analogue. Preparation, autoradiography and preliminary PET investigations. Nuclear Medicine and Biology. 20: 249-55. PMID 8485483 DOI: 10.1016/0969-8051(93)90045-V |
0.361 |
|
| 1993 |
Litton JE, Neiman J, Pauli S, Farde L, Hindmarsh T, Halldin C, Sedvall G. PET analysis of [11C]flumazenil binding to benzodiazepine receptors in chronic alcohol-dependent men and healthy controls. Psychiatry Research. 50: 1-13. PMID 8390063 DOI: 10.1016/0925-4927(93)90019-E |
0.614 |
|
| 1993 |
Schoeps KO, Halldin C, NÃ¥gren K, Swahn CG, Karlsson P, Hall H, Farde L. Preparation of [1-11C]dopamine, [1-11C]p-tyramine and [1-11C]m-tyramine. Autoradiography and PET examination of [1-11C]dopamine in primates. Nuclear Medicine and Biology. 20: 669-78. PMID 8358354 DOI: 10.1016/0969-8051(93)90038-V |
0.501 |
|
| 1993 |
Halldin C, Foged C, Farde L, Karlsson P, Hansen K, Grønvald F, Swahn CG, Hall H, Sedvall G. [11C]NNC 687 and [11C]NNC 756, dopamine D-1 receptor ligands. Preparation, autoradiography and PET investigation in monkey. Nuclear Medicine and Biology. 20: 945-53. PMID 8298574 DOI: 10.1016/0969-8051(93)90095-C |
0.673 |
|
| 1993 |
Farde L, Nordström AL. PET examination of central D2 dopamine receptor occupancy in relation to extrapyramidal syndromes in patients being treated with neuroleptic drugs. Psychopharmacology Series. 10: 94-100. PMID 8103229 DOI: 10.1007/978-3-642-78010-3_9 |
0.454 |
|
| 1993 |
Nordström AL, Farde L, Wiesel FA, Forslund K, Pauli S, Halldin C, Uppfeldt G. Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients. Biological Psychiatry. 33: 227-35. PMID 8097114 DOI: 10.1016/0006-3223(93)90288-O |
0.519 |
|
| 1993 |
Karlsson P, Farde L, Halldin C, Swahn CG, Sedvall G, Foged C, Hansen KT, Skrumsager B. PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor. Psychopharmacology. 113: 149-56. PMID 7855175 DOI: 10.1007/Bf02245691 |
0.682 |
|
| 1993 |
Nordström AL, Farde L, Halldin C. High 5-HT2 receptor occupancy in clozapine treated patients demonstrated by PET. Psychopharmacology. 110: 365-7. PMID 7831432 DOI: 10.1007/Bf02251294 |
0.419 |
|
| 1993 |
Nyberg S, Farde L, Eriksson L, Halldin C, Eriksson B. 5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone. Psychopharmacology. 110: 265-72. PMID 7530376 DOI: 10.1007/Bf02251280 |
0.497 |
|
| 1992 |
Farde L. Selective D1- and D2-dopamine receptor blockade both induces akathisia in humans--a PET study with [11C]SCH 23390 and [11C]raclopride. Psychopharmacology. 107: 23-9. PMID 1534178 DOI: 10.1007/Bf02244961 |
0.57 |
|
| 1992 |
Nordström AL, Farde L, Halldin C. Time course of D2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol. Psychopharmacology. 106: 433-8. PMID 1533719 DOI: 10.1007/Bf02244811 |
0.486 |
|
| 1992 |
Sedvall CG, Farde L, Hall H, Halldin C, Karlsson P, Brene S, Lindefors N, Persson H, Chipkin RE, Ehrlich M. Ligand selection for PET studies of D1 dopamine receptors. Relationship between distribution of binding sites and mRNA for DAARPP32 in the human brain. Clinical Neuropharmacology. 15: 466A-467A. PMID 1386781 |
0.423 |
|
| 1992 |
Hall H, Farde L, Halldin C, Högberg T, Larsson S, Sedvall G. Imaging of dopamine receptors using PET and SPECT. Neurochemistry International. 20: 329S-333S. PMID 1365450 DOI: 10.1016/0197-0186(92)90260-X |
0.621 |
|
| 1992 |
Farde L, Nordström AL. PET analysis indicates atypical central dopamine receptor occupancy in clozapine-treated patients. The British Journal of Psychiatry. Supplement. 30-3. PMID 1358126 DOI: 10.1192/S0007125000296888 |
0.446 |
|
| 1992 |
Farde L, Nordström AL, Halldin C, Wiesel FA, Sedvall G. PET studies of dopamine receptors in relation to antipsychotic drug treatment. Clinical Neuropharmacology. 15: 468A-469A. PMID 1354052 |
0.563 |
|
| 1992 |
Farde L, Nordström AL, Wiesel FA, Pauli S, Halldin C, Sedvall G. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Archives of General Psychiatry. 49: 538-44. PMID 1352677 DOI: 10.1001/Archpsyc.1992.01820070032005 |
0.58 |
|
| 1992 |
Halldin C, Farde L, Litton JE, Hall H, Sedvall G. [11C]Ro 15-4513, a ligand for visualization of benzodiazepine receptor binding. Preparation, autoradiography and positron emission tomography. Psychopharmacology. 108: 16-22. PMID 1329130 DOI: 10.1007/Bf02245279 |
0.668 |
|
| 1992 |
Pauli S, Liljequist S, Farde L, Swahn CG, Halldin C, Litton JE, Sedvall G. PET analysis of alcohol interaction with the brain disposition of [11C]flumazenil. Psychopharmacology. 107: 180-5. PMID 1319600 DOI: 10.1007/Bf02245135 |
0.59 |
|
| 1992 |
Farde L, Hall H. Positron emission tomography--examination of chemical transmission in the living human brain. Development of radioligands. Arzneimittel-Forschung. 42: 260-4. PMID 1316756 |
0.477 |
|
| 1992 |
SEDVALL G, FARDE L, NORDSTROM A. PET SCANNING OF DOPAMINE RECEPTORS AND PSYCHOSIS Behavioural Pharmacology. 3: 21. DOI: 10.1097/00008877-199204001-00061 |
0.591 |
|
| 1992 |
Nyberg S, Farde L, Halldin C, Eriksson B. PET Examination of Central D2 dopamine and 5-HT2 Receptor Occupancy by Risperidone Clinical Neuropharmacology. 15: 198B. DOI: 10.1097/00002826-199202001-00380 |
0.471 |
|
| 1992 |
Hall H, Farde L, Litton JE, Halldin C, Sedvall G. PET AND AUTORADIOGRAPHY OF BENZODIAZEPINE RECEPTOR BINDING WITH RADIOLABELLED FLUMAZENIL AND RO 15-4513. Clinical Neuropharmacology. 15: 29B. DOI: 10.1097/00002826-199202001-00054 |
0.62 |
|
| 1992 |
Nordström A, Farde L, Pauli S, Litton J, Halldin C. PET analysis of central [11C]raclopride binding in healthy young adults and schizophrenic patients-reliability and age effects Human Psychopharmacology: Clinical and Experimental. 7: 157-165. DOI: 10.1002/Hup.470070302 |
0.52 |
|
| 1992 |
Swahn CG, Farde L, Halldin C, Sedvall G. Ligand metabolites in plasma during PET-studies with the 11C-labelled dopamine antagonists, raclopride, SCH 23390 and N-methylspiroperidol Human Psychopharmacology. 7: 97-103. DOI: 10.1002/Hup.470070204 |
0.592 |
|
| 1991 |
Halldin C, Farde L, Högberg T, Hall H, Ström P, Ohlberger A, Solin O. A comparative PET-study of five carbon-11 or fluorine-18 labelled salicylamides. Preparation and in vitro dopamine D-2 receptor binding. International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology. 18: 871-81. PMID 1839303 DOI: 10.1016/0883-2897(91)90096-4 |
0.507 |
|
| 1991 |
Sedvall G, Farde L, Barnett A, Hall H, Halldin C. 11C-SCH 39166, a selective ligand for visualization of dopamine-D1 receptor binding in the monkey brain using PET. Psychopharmacology. 103: 150-3. PMID 1674157 DOI: 10.1007/Bf02244195 |
0.685 |
|
| 1991 |
Hall H, Högberg T, Halldin C, Köhler C, Ström P, Ross SB, Larsson SA, Farde L. NCQ 298, a new selective iodinated salicylamide ligand for the labelling of dopamine D2 receptors. Psychopharmacology. 103: 6-18. PMID 1672460 DOI: 10.1007/Bf02244067 |
0.532 |
|
| 1991 |
Eriksson L, Farde L, Rosenquist G. Kinetic analysis of receptor binding with positron emission tomography. Acta Radiologica. Supplementum. 376: 126-7. PMID 1666746 |
0.332 |
|
| 1991 |
Halldin C, Farde L, Hall H, Högberg T, Printz G, Pulka W, Sedvall G, Solin O. Synthesis of five benzamide analogs. Comparison with positron emission tomography. Acta Radiologica. Supplementum. 376: 121-2. PMID 1666743 |
0.462 |
|
| 1991 |
Halldin C, Farde L, Barnett A, Sedvall G. Synthesis of carbon-11 labelled SCH 39166, a new selective dopamine D-1 receptor ligand, and preliminary PET investigations. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 42: 451-5. PMID 1646191 DOI: 10.1016/0883-2889(91)90105-A |
0.643 |
|
| 1991 |
Pauli S, Farde L, Halldin C, Sedvall G. Occupancy of the central benzodiazepine receptors during benzodiazepine treatment determined by PET European Neuropsychopharmacology. 1: 229-231. DOI: 10.1016/0924-977X(91)90498-J |
0.593 |
|
| 1991 |
Sedval G, Farde L, Karlsson P, Nordström A, Chipkin R. PET studies of D1 and D2 dopamine receptors in drug naive schizophrenic patients European Neuropsychopharmacology. 1: 221-223. DOI: 10.1016/0924-977X(91)90495-G |
0.482 |
|
| 1990 |
Halldin C, Farde L, Högberg T, Hall H, Sedvall G. Carbon-11 labelling of eticlopride in two different positions--a selective high-affinity ligand for the study of dopamine D-2 receptors using PET. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 41: 669-74. PMID 2170298 DOI: 10.1016/0883-2889(90)90082-R |
0.645 |
|
| 1990 |
Blomqvist G, Pauli S, Farde L, Eriksson L, Persson A, Halldin C. Maps of receptor binding parameters in the human brain--a kinetic analysis of PET measurements. European Journal of Nuclear Medicine. 16: 257-65. PMID 2112470 DOI: 10.1007/Bf00842777 |
0.519 |
|
| 1990 |
Wiesel FA, Farde L, Nordström AL, Sedvall G. Central D1- and D2-receptor occupancy during antipsychotic drug treatment. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 14: 759-67. PMID 1981395 DOI: 10.1016/0278-5846(90)90046-J |
0.645 |
|
| 1990 |
Farde L, von Bahr C. Distribution of remoxipride to the human brain and central D2-dopamine receptor binding examined in vivo by PET. Acta Psychiatrica Scandinavica. Supplementum. 358: 67-71. PMID 1978494 DOI: 10.1111/j.1600-0447.1990.tb05292.x |
0.502 |
|
| 1990 |
Hall H, Wedel I, Halldin C, Kopp J, Farde L. Comparison of the in vitro receptor binding properties of N-[3H]methylspiperone and [3H]raclopride to rat and human brain membranes. Journal of Neurochemistry. 55: 2048-57. PMID 1977888 DOI: 10.1111/J.1471-4159.1990.Tb05794.X |
0.428 |
|
| 1990 |
Farde L, Wiesel FA, Stone-Elander S, Halldin C, Nordström AL, Hall H, Sedvall G. D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride. Archives of General Psychiatry. 47: 213-9. PMID 1968328 DOI: 10.1001/Archpsyc.1990.01810150013003 |
0.669 |
|
| 1990 |
Farde L, Nordstrom A, Wiesel F, Halldin C, Sedvall G. D1- and D2-dopamine receptor occupancy during treatment with classical and atypical neurpleptics Schizophrenia Research. 3: 51-52. DOI: 10.1016/0920-9964(90)90133-R |
0.539 |
|
| 1989 |
Farde L, Wiesel FA, Nilsson L, Sedvall G. The potential of positron-emission tomography for pharmacokinetic and pharmacodynamic studies of neuroleptics. Psychopharmacology Series. 7: 32-9. PMID 2574454 DOI: 10.1007/978-3-642-74430-3_4 |
0.496 |
|
| 1989 |
Wiesel FA, Farde L, Halldin C. Clinical melperone treatment blocks D2-dopamine receptors in the human brain as determined by PET. Acta Psychiatrica Scandinavica. Supplementum. 352: 30-4. PMID 2573239 DOI: 10.1111/j.1600-0447.1989.tb06433.x |
0.457 |
|
| 1989 |
Farde L, Wiesel FA, Nordström AL, Sedvall G. D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics. Psychopharmacology. 99: S28-31. PMID 2573104 DOI: 10.1007/BF00442555 |
0.627 |
|
| 1989 |
Farde L, Eriksson L, Blomquist G, Halldin C. Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 9: 696-708. PMID 2528555 DOI: 10.1038/Jcbfm.1989.98 |
0.568 |
|
| 1989 |
Halldin C, Högberg T, Stone-Elander S, Farde L, Hall H, Printz G, Solin O, Sedvall G. Synthesis of [ethyl-18F]fluororaclopride for the in vivo study of dopamine D2 receptors using PET Journal of Labelled Compounds and Radiopharmaceuticals. 26: 338-339. DOI: 10.1002/JLCR.25802601146 |
0.373 |
|
| 1989 |
Persson A, Pauli S, Halldin C, Stone-Elander S, Farde L, Sjögren I, Sedvall G. Saturation analysis of specific11C Ro 15-1788 binding to the human neocortex using positron emission tomography Human Psychopharmacology: Clinical and Experimental. 4: 21-31. DOI: 10.1002/Hup.470040105 |
0.649 |
|
| 1989 |
Farde L, Wiesel FA, Halldin C, Sedvall G, Nilsson L. Dopamine Receptor Occupancy and Plasma Haloperidol Levels-Reply Archives of General Psychiatry. 46: 483-484. DOI: 10.1001/Archpsyc.1989.01810050097022 |
0.586 |
|
| 1988 |
Farde L, Pauli S, Hall H, Eriksson L, Halldin C, Högberg T, Nilsson L, Sjögren I, Stone-Elander S. Stereoselective binding of 11C-raclopride in living human brain - a search for extrastriatal central D2-dopamine receptors by PET Psychopharmacology. 94: 471-478. PMID 3131792 DOI: 10.1007/Bf00212840 |
0.564 |
|
| 1988 |
Farde L, Wiesel FA, Jansson P, Uppfeldt G, Wahlen A, Sedvall G. An open label trial of raclopride in acute schizophrenia. Confirmation of D2-dopamine receptor occupancy by PET. Psychopharmacology. 94: 1-7. PMID 3126517 DOI: 10.1007/BF00735871 |
0.645 |
|
| 1988 |
Sedvall G, Farde L, Hall H, Pauli S, Persson A, Wiesel FA. PET scanning--a new tool in clinical psychopharmacology. Psychopharmacology Series. 5: 27-33. PMID 3045802 DOI: 10.1007/978-3-642-73280-5_3 |
0.692 |
|
| 1988 |
Hall H, Köhler C, Gawell L, Farde L, Sedvall G. Raclopride, a new selective ligand for the dopamine-D2 receptors. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 12: 559-68. PMID 2975809 DOI: 10.1016/0278-5846(88)90001-2 |
0.673 |
|
| 1988 |
Andreasen NC, Carson R, Diksic M, Evans A, Farde L, Gjedde A, Hakim A, Lal S, Nair N, Sedvall G. Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatum. Schizophrenia Bulletin. 14: 471-84. PMID 2975043 DOI: 10.1093/SCHBUL/14.3.471 |
0.655 |
|
| 1988 |
Hall H, Farde L, Sedvall G. Human dopamine receptor subtypes--in vitro binding analysis using 3H-SCH 23390 and 3H-raclopride. Journal of Neural Transmission. 73: 7-21. PMID 2969950 DOI: 10.1007/BF01244618 |
0.655 |
|
| 1988 |
Farde L, Grind M, Nilsson MI, Ogenstad S, Sedvall G. Remoxipride--a new potential antipsychotic drug. Pharmacological effects and pharmacokinetics following repeated oral administration in male volunteers. Psychopharmacology. 95: 157-61. PMID 2901121 DOI: 10.1007/BF00174501 |
0.481 |
|
| 1988 |
Farde L, Wiesel FA, Halldin C, Sedvall G. Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Archives of General Psychiatry. 45: 71-6. PMID 2892477 DOI: 10.1001/Archpsyc.1988.01800250087012 |
0.62 |
|
| 1988 |
Farde L. Brain Dopamine Receptors in Schizophrenia: PET Problems-Reply Archives of General Psychiatry. 45: 599. DOI: 10.1001/Archpsyc.1988.01800300097018 |
0.507 |
|
| 1987 |
Lindvall O, Backlund EO, Farde L, Sedvall G, Freedman R, Hoffer B, Nobin A, Seiger A, Olson L. Transplantation in Parkinson's disease: two cases of adrenal medullary grafts to the putamen. Annals of Neurology. 22: 457-68. PMID 3435067 DOI: 10.1002/Ana.410220403 |
0.492 |
|
| 1987 |
Farde L, Halldin C, Stone-Elander S, Sedvall G. PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride. Psychopharmacology. 92: 278-84. PMID 2957716 DOI: 10.1007/Bf00210831 |
0.682 |
|
| 1987 |
Sedvall G, Farde L, Wiesel FA. Quantitative determination of D2 dopamine receptor characteristics in healthy human subjects and psychiatric patients. Life Sciences. 41: 813-6. PMID 2956473 DOI: 10.1016/0024-3205(87)90169-X |
0.605 |
|
| 1987 |
Farde L, Wiesel FA, Hall H, Halldin C, Stone-Elander S, Sedvall G. No D2 receptor increase in PET study of schizophrenia. Archives of General Psychiatry. 44: 671-2. PMID 2955770 DOI: 10.1001/Archpsyc.1987.01800190091013 |
0.659 |
|
| 1987 |
Sedvall G, Ehrin E, Farde L. Stereoselective binding of11C-labelled piquindone (Ro 22-1319) to dopamine-D2 receptors in the living human brain Human Psychopharmacology: Clinical and Experimental. 2: 23-30. DOI: 10.1002/HUP.470020105 |
0.7 |
|
| 1986 |
Halldin C, Stone-Elander S, Farde L, Ehrin E, Fasth KJ, Långström B, Sedvall G. Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 37: 1039-43. PMID 3027000 DOI: 10.1016/0883-2889(86)90044-4 |
0.65 |
|
| 1986 |
Sedvall G, Farde L, Persson A, Wiesel FA. Imaging of neurotransmitter receptors in the living human brain. Archives of General Psychiatry. 43: 995-1005. PMID 3019270 DOI: 10.1001/Archpsyc.1986.01800100089012 |
0.601 |
|
| 1986 |
Sedvall G, Farde L, Stone-Elander S, Halldin C. Dopamine D1-receptor binding in the living human brain. Advances in Experimental Medicine and Biology. 204: 119-24. PMID 2947423 DOI: 10.1007/978-1-4684-5191-7_7 |
0.637 |
|
| 1986 |
Farde L, Hall H, Ehrin E, Sedvall G. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science (New York, N.Y.). 231: 258-61. PMID 2867601 DOI: 10.1126/SCIENCE.2867601 |
0.69 |
|
| 1985 |
Ehrin E, Farde L, de Paulis T, Eriksson L, Greitz T, Johnström P, Litton JE, Nilsson JL, Sedvall G, Stone-Elander S. Preparation of 11C-labelled Raclopride, a new potent dopamine receptor antagonist: preliminary PET studies of cerebral dopamine receptors in the monkey. The International Journal of Applied Radiation and Isotopes. 36: 269-73. PMID 3874833 DOI: 10.1016/0020-708X(85)90083-3 |
0.67 |
|
| 1985 |
Farde L, Ehrin E, Eriksson L, Greitz T, Hall H, Hedström CG, Litton JE, Sedvall G. Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. Proceedings of the National Academy of Sciences of the United States of America. 82: 3863-7. PMID 3873656 DOI: 10.1073/PNAS.82.11.3863 |
0.701 |
|
| 1985 |
Persson A, Ehrin E, Eriksson L, Farde L, Hedström CG, Litton JE, Mindus P, Sedvall G. Imaging of [11C]-labelled Ro 15-1788 binding to benzodiazepine receptors in the human brain by positron emission tomography. Journal of Psychiatric Research. 19: 609-22. PMID 3001301 DOI: 10.1016/0022-3956(85)90080-9 |
0.66 |
|
| 1984 |
Widén L, Blomqvist G, DePaulis T, Ehrin E, Eriksson L, Farde L, Greitz T, Hedström CG, Ingvar DH, Litton JE, Nilsson JL, Ögren SO, Sedvall G, Stone-Slander S, Wiesel F-, et al. STUDIES OF SCHIZOPHRENIA WITH POSITRON CT Clinical Neuropharmacology. 7: S295. DOI: 10.1097/00002826-198406001-00266 |
0.496 |
|
| Show low-probability matches. |
